<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Sequencing of chemotherapy and radiotherapy for early breast cancer - Hickey, BE - 2013 | Cochrane Library</title> <meta content="Sequencing of chemotherapy and radiotherapy for early breast cancer - Hickey, BE - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005212.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Sequencing of chemotherapy and radiotherapy for early breast cancer - Hickey, BE - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005212.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD005212.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Sequencing of chemotherapy and radiotherapy for early breast cancer" name="citation_title"/> <meta content="Brigid E Hickey" name="citation_author"/> <meta content="Princess Alexandra Hospital" name="citation_author_institution"/> <meta content="Brigid_Hickey@health.qld.gov.au" name="citation_author_email"/> <meta content="Daniel P Francis" name="citation_author"/> <meta content="Queensland Health" name="citation_author_institution"/> <meta content="Margot Lehman" name="citation_author"/> <meta content="Princess Alexandra Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD005212.pub3" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/04/30" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005212.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005212.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005212.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anemia [etiology]; Breast Neoplasms [*drug therapy, mortality, *radiotherapy, surgery]; Chemotherapy, Adjuvant [adverse effects, *methods]; Pigmentation Disorders [etiology]; Radiotherapy, Adjuvant [adverse effects, *methods]; Randomized Controlled Trials as Topic; Telangiectasis [etiology]; Time Factors" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005212.pub3&amp;doi=10.1002/14651858.CD005212.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="f00EizoA";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005212\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005212\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005212\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005212\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","hr","fr","ta"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005212.pub3",title:"Sequencing of chemotherapy and radiotherapy for early breast cancer",firstPublishedDate:"Apr 30, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Breast Cancer Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=f00EizoA&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005212.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005212.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD005212.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD005212.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005212.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD005212.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ta&quot;,&quot;title&quot;:&quot;எளியமொழிச் சுருக்கம்&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005212.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD005212.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD005212.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005212.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3464 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD005212.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#CD005212-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#CD005212-sec-0073"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#CD005212-sec-0022"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#CD005212-sec-0027"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#CD005212-sec-0028"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#CD005212-sec-0049"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#CD005212-sec-0067"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/appendices#CD005212-sec-0078"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/table_n/CD005212StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/table_n/CD005212StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Sequencing of chemotherapy and radiotherapy for early breast cancer</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/information#CD005212-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Brigid E Hickey</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/information#CD005212-cr-0003">Daniel P Francis</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005212.pub3/information#CD005212-cr-0004">Margot Lehman</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/information/en#CD005212-sec-0087">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 30 April 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD005212.pub3">https://doi.org/10.1002/14651858.CD005212.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD005212-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005212-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005212-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005212-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD005212-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD005212-abs-0001" lang="en"> <section id="CD005212-sec-0001"> <h3 class="title" id="CD005212-sec-0001">Background</h3> <p>After surgery for localised breast cancer, radiotherapy (RT) improves both local control and breast cancer‐specific survival. In patients at risk of harbouring micro‐metastatic disease, adjuvant chemotherapy (CT) improves 15‐year survival. However, the best sequence of administering these two types of adjuvant therapy for early‐stage breast cancer is unclear. </p> </section> <section id="CD005212-sec-0002"> <h3 class="title" id="CD005212-sec-0002">Objectives</h3> <p>To determine the effects of different sequencing of adjuvant CT and RT for women with early breast cancer. </p> </section> <section id="CD005212-sec-0003"> <h3 class="title" id="CD005212-sec-0003">Search methods</h3> <p>An updated search was carried out in the Cochrane Breast Cancer Group's Specialised Register (20 May 2011), MEDLINE (14 December 2011), EMBASE (20 May 2011) and World Health Organization (WHO) International Clinical Trials Registry Platform (20 May 2011). Details of the search strategy and methods of coding for the Specialised Register are described in the Group's module in <i>The Cochrane Library</i>. We extracted studies that had been coded as 'early', 'chemotherapy' and 'radiotherapy'. </p> </section> <section id="CD005212-sec-0004"> <h3 class="title" id="CD005212-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials evaluating different sequencing of CT and RT. </p> </section> <section id="CD005212-sec-0005"> <h3 class="title" id="CD005212-sec-0005">Data collection and analysis</h3> <p>We assessed the eligibility and quality of the identified studies and extracted data from the published reports of the included trials. We derived odds ratios (OR) and hazard ratios (HR) from the available numerical data. Toxicity data were extracted, where reported. We used a fixed‐effect model for meta‐analysis and conducted analyses on the basis of the method of sequencing of the two treatments. </p> </section> <section id="CD005212-sec-0006"> <h3 class="title" id="CD005212-sec-0006">Main results</h3> <p>Three trials reporting two different sequencing comparisons were identified. There were no significant differences between the various methods of sequencing adjuvant therapy for local recurrence‐free survival, overall survival, relapse‐free survival and metastasis‐free survival based on 1166 randomised women in three trials. Concurrent chemoradiation increased anaemia (OR 1.54; 95% confidence interval (CI) 1.10 to 2.15), telangiectasia (OR 3.85; 95% CI 1.37 to 10.87) and pigmentation (OR 15.96; 95% CI 2.06 to 123.68). Treated women did not report worse cosmesis with concurrent chemoradiation but physician‐reported assessments did (OR 1.14; 95% CI 0.42 to 3.07). Other measures of toxicity did not differ between the two types of sequencing. On the basis of one trial (244 women), RT before CT was associated with an increased risk of neutropenic sepsis (OR 2.96; 95% CI 1.26 to 6.98) compared with CT before RT, but other measures of toxicity did not differ. </p> </section> <section id="CD005212-sec-0007"> <h3 class="title" id="CD005212-sec-0007">Authors' conclusions</h3> <p>The data included in this review, from three well‐conducted randomised trials, suggest that different methods of sequencing CT and RT do not appear to have a major effect on recurrence or survival for women with breast cancer if RT is commenced within seven months after surgery. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD005212-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005212-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005212-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005212-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD005212-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ta#CD005212-abs-0008">தமிழ்</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD005212-abs-0005">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD005212-abs-0004" lang="en"> <h3>Sequencing of chemotherapy and radiotherapy for women following surgery for early breast cancer </h3> <p>Both chemotherapy and radiotherapy reduce the risk of breast cancer recurring and the risk of dying from breast cancer. Generally, these therapies are given after surgery but there is uncertainty about whether they should be given at the same time (concurrently) or one after the other (sequentially). If they are used sequentially, the radiotherapy or the chemotherapy could be used first and concerns have been expressed that the effectiveness of the therapy that is delayed might be reduced. However, it has also been suggested that using chemotherapy and radiotherapy at the same time may be more toxic than keeping them separate. This review examined the current evidence on the best way to administer chemotherapy and radiotherapy following breast‐conserving surgery. We were able to include three randomised trials. Two of these, with 853 women, assessed radiotherapy and chemotherapy given at the same time versus chemotherapy given first followed by radiotherapy. The third trial randomised 244 women to radiotherapy followed by chemotherapy versus chemotherapy followed by radiotherapy. The evidence produced by these three well‐conducted trials suggests that recurrence of a woman's cancer and her chances of dying from breast cancer are similar regardless of the order of the treatments, provided that both radiotherapy and chemotherapy are commenced within seven months of the surgery. The trials provided limited information regarding adverse events, side effects or quality of life associated with the different sequences of treatment. The limited evidence available does suggest that the frequency and severity of side effects of chemotherapy and radiotherapy are similar regardless of which sequence is used. However, it should be noted that the women in these trials were treated, on average, in the early 2000s. As a result, the trials do not assess the modern types of radiotherapy, and new types of chemotherapy (such as taxanes) or other drugs (such as Herceptin). We will add relevant trials that include these more recent treatments to future updates of this review. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD005212-sec-0073" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD005212-sec-0073"></div> <h3 class="title" id="CD005212-sec-0074">Implications for practice</h3> <section id="CD005212-sec-0074"> <p>Evidence from three well‐conducted RCTs indicated that local control and overall survival is similar for concurrent CT and RT, RT followed by CT, and CT followed by RT for women with early breast cancer when the RT was commenced within seven months after surgery (as this was the maximum delay in the included studies). These data were based on the use of first‐generation chemotherapeutic agents (thus excluding anthracyclines and taxanes) for the comparison of concurrent versus sequential CT. </p> </section> <h3 class="title" id="CD005212-sec-0075">Implications for research</h3> <section id="CD005212-sec-0075"> <p>RCTs are needed to assess the relative effects of sequencing traditional and new RT techniques with new CT regimens and biological therapies, including taxanes and Herceptin. Future trials should collect data on costs, QoL, and patient preference; as well as on local and distant recurrence, cause specific mortality and harms. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD005212-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD005212-sec-0022"></div> <section id="CD005212-sec-0023"> <h3 class="title" id="CD005212-sec-0023">Description of the condition</h3> <p>For women with localised breast cancer who undergo conservative surgery or mastectomy, adjuvant radiotherapy (RT) reduces the risk of local recurrence and improves breast cancer‐specific survival (<a href="./references#CD005212-bbs2-0045" title="Early Breast Cancer Trialists' Collaborative Group (EBCTCG), DarbyS , McGaleP , CorreaC , TaylorC , ArriagadaR , ClarkeM , et al. Effect of radiotherapy after breast‐conserving surgery on 10‐year recurrence and 15‐year breast cancer death: meta‐analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet2011;378(804):1707‐16. ">EBCTCG 2011</a>; <a href="./references#CD005212-bbs2-0067" title="RagazJ , OlivettoI , SpinelliJ , PhillipsN , JacksonS , WilsonK , et al. Locoregional radiation therapy in patients with high risk breast cancer receiving adjuvant chemotherapy: 20‐year results of the British Columbia randomised trial. Journal of the National Cancer Institute2005;97(2):116‐26. ">Ragaz 2005</a>). Adjuvant chemotherapy (CT) has also been shown to improve 15‐year survival (<a href="./references#CD005212-bbs2-0044" title="Early Breast Cancer Trialists Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15‐year survival: an overview of the randomised trials. Lancet2005;365:1687‐717. ">EBCTCG 2005b</a>). </p> </section> <section id="CD005212-sec-0024"> <h3 class="title" id="CD005212-sec-0024">Description of the intervention</h3> <p>Current practices for the sequencing of RT and CT include administering CT before RT, administering CT and RT concurrently, or 'sandwiching' RT in the middle of the CT course. It is not clear which of these different sequences is the most effective for women with early‐stage breast cancer. It has been suggested that the sequence of these two treatments may affect patient outcome (<a href="./references#CD005212-bbs2-0068" title="RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Recht 1996</a>). For example, a delay in initiating RT was found to increase the risk of local recurrence (odds ratio (OR) 2.28, 95% confidence interval (CI) 1.45 to 3.57) (<a href="./references#CD005212-bbs2-0054" title="HuangJ , BarberaL , BrouwersM , BrowmanG , MackillopWJ . Does delay in starting treatment affect the outcomes of radiation therapy? A systematic review. Journal of Clinical Oncology2002;21(3):555‐63. ">Huang 2003</a>). However, a delay in commencing CT may also have a detrimental effect on survival. </p> </section> <section id="CD005212-sec-0025"> <h3 class="title" id="CD005212-sec-0025">How the intervention might work</h3> <p>One published randomised trial initially found a non‐significant improvement in overall survival if CT was given first (<a href="./references#CD005212-bbs2-0068" title="RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Recht 1996</a>) but longer follow‐up did not reveal any difference in the rates of local or distant recurrence or death between the two treatment groups (<a href="./references#CD005212-bbs2-0035" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiotherapy for patients with early stage breast cancer: updated results of a prospective randomized trial [abstract]. International Journal of Radiation Oncology Biology Physics2001;51Suppl 3(2a):2‐3. ">Bellon 2001</a>). Additionally, some non‐randomised studies have suggested that delaying RT while CT is administered first could increase local recurrence rates (<a href="./references#CD005212-bbs2-0036" title="BuchholzTA , Austin‐SeymourMM , MoeRE , EllisGK , LivingstonRB , PeltonJG , et al. Effect of delay in radiation in the combined modality treatment of breast cancer. International Journal of Radiation Oncology Biology Physics1993;26(1):23‐35. ">Buchholz 1993</a>; <a href="./references#CD005212-bbs2-0037" title="BuchholzTA , HuntKK , AmossonCM , TuckerSL , StromEA , McNeeseMD , et al. Sequencing of chemotherapy and radiation in lymph node‐negative breast cancer. Cancer Journal from Scientific American1999;5(3):159‐64. ">Buchholz 1999</a>; <a href="./references#CD005212-bbs2-0008" title="BuzdarAU , KauSW , SmithTL , AmesF , SingletaryE , StromE , et al. The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer. Cancer1993;71(11):3680‐7. ">Buzdar 1993</a>; <a href="./references#CD005212-bbs2-0011" title="DonatoV , MonacoA , MessinaF , DeSanctisV , MessineoD , BanellisE , et al. Local recurrence in breast cancer after conservative surgery: timing of radiotherapy and sequencing of chemotherapy. Anticancer Research2004;24(2C):1303‐6. ">Donato 2004</a>; <a href="./references#CD005212-bbs2-0017" title="HartsellWR , RecineDC , GriemKL , MurthyAK . Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence. Cancer1995;76(12):2497‐503. ">Hartsell 1995</a>; <a href="./references#CD005212-bbs2-0022" title="LeonardCE , WoodME , ZhenB , RankinJ , WaitzDa , NortonL , et al. Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control?. Journal of Clinical Oncology1995;13(12):2906‐15. ">Leonard 1995</a>; <a href="./references#CD005212-bbs2-0064" title="McCormickB , NortonL , YaoTJ , YahalomJ , PetrekJA . The impact of the sequence of radiation and chemotherapy on local control after breast‐conserving surgery. Cancer Journal from Scientific American1996;2(1):39. ">McCormick 1996</a>; <a href="./references#CD005212-bbs2-0065" title="MeekAG , ParkTL , WeissTA , BethuneWA . Effect of delayed radiation therapy on local control in breast conservation therapy. Radiology1996;200(3):615‐9. ">Meek 1996</a>; <a href="./references#CD005212-bbs2-0023" title="RechtA , ComeSE , GelmanRS , GoldsteinM , TishlerS , GoreSM , et al. Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early stage, node positive breast cancer: sequencing, timing and outcome. Journal of Clinical Oncology1991;9(9):1662‐7. ">Recht 1991</a>; <a href="./references#CD005212-bbs2-0070" title="SlotmanBJ , MeyerOW , NjoKH , KarimAB . Importance of timing of radiotherapy in breast conserving treatment for early stage breast cancer. Radiotherapy and Oncology1994;30(3):206‐12. ">Slotman 1994</a>). Conversely, a delay in the administration of systemic CT while RT is delivered could allow the proliferation of micro‐metastatic disease to an extent that it can no longer be dealt with adequately by the CT. </p> </section> <section id="CD005212-sec-0026"> <h3 class="title" id="CD005212-sec-0026">Why it is important to do this review</h3> <p>In many parts of the world there are waiting lists for RT (<a href="./references#CD005212-bbs2-0033" title="AshDV . Waiting times for cancer treatment [editorial]. Clinical Oncology (Royal College of Radiologists)2000;12(140):3. ">Ash 2000</a>; <a href="./references#CD005212-bbs2-0055" title="KennyL , LehmanM . Sequential audit of unacceptable delays in radiation therapy in Australia and New Zealand. Australasian Radiology2004;48(1):29‐34. ">Kenny 2004</a>; <a href="./references#CD005212-bbs2-0059" title="MacKillopWJ , FuHU , QuirtCF , DixonP , BrundageM , Zhou , Y . Waiting for radiation therapy in Ontario. International Journal of Radiation Oncology, Biology, Physics1994;30(1):221‐8. ">MacKillop 1994</a>; <a href="./references#CD005212-bbs2-0060" title="MacKillopWJ , QuirtCF . A comparison of delays in treatment of cancer with radiation therapy in Canada and the United States. International Journal of Radiation Oncology, Biology, Physics1995;32(2):531‐9. ">MacKillop 1995</a>). The delivery of CT first allows patients to start treatment and overcomes the problem of RT waiting lists (<a href="./references#CD005212-bbs2-0055" title="KennyL , LehmanM . Sequential audit of unacceptable delays in radiation therapy in Australia and New Zealand. Australasian Radiology2004;48(1):29‐34. ">Kenny 2004</a>). </p> <p>If a systematic review helps to resolve this uncertainty about the relative effects of different sequences of CT and RT, it will assist in making these choices. For example, if it shows that sequencing of the two treatments makes little or no difference for cancer‐related outcomes such as survival and local recurrence, then choosing to give CT first may be preferable for both logistic reasons and patient preference. </p> <p>This 2011 review is an update of the Cochrane systematic review first published in 2006. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD005212-sec-0027" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD005212-sec-0027"></div> <p>To determine the effects of different sequencing of RT and CT for women with early‐stage breast cancer who have been treated surgically. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD005212-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD005212-sec-0028"></div> <section id="CD005212-sec-0029"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD005212-sec-0030"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) evaluating different ways of sequencing RT and CT were eligible. The comparison between different sequences had to be unconfounded (i.e. the randomised groups differed only in relation to the sequencing of the two treatments). Trials incorporating the use of other adjuvant treatments, such as monoclonal antibodies or hormonal therapy, were eligible if these other treatments were applied in both groups in the RCT. Published and unpublished studies were eligible. </p> </section> <section id="CD005212-sec-0031"> <h4 class="title">Types of participants</h4> <p>Women with surgically treated, histologically confirmed early‐stage breast cancer who required both adjuvant CT and RT were included. Early breast cancer included tumours classified as Union for International Cancer Control (UICC) stage T1‐3N0‐1M0. Surgery could comprise mastectomy, lumpectomy, wide local excision or quadrantectomy, with or without axillary dissection, axillary sampling or sentinel node biopsy. Women who had previously received adjuvant therapy for breast cancer were not eligible. </p> </section> <section id="CD005212-sec-0032"> <h4 class="title">Types of interventions</h4> <p>The following comparisons were eligible:</p> <p> <ol id="CD005212-list-0001"> <li> <p>adjuvant RT followed by adjuvant CT versus adjuvant CT followed by adjuvant RT;</p> </li> <li> <p>adjuvant CT followed by adjuvant RT versus a 'sandwich technique' (when one or more courses of CT were followed by RT, which was followed by further CT); </p> </li> <li> <p>adjuvant CT followed by adjuvant RT versus concurrent adjuvant CT and RT.</p> </li> </ol> </p> <p>CT regimens included those delivered at standard doses (i.e. not high dose), and could include drugs such as cyclophosphamide, 5‐fluorouracil, anthracyclines, taxanes and other agents. </p> <p>RT had to be delivered to the breast or chest wall, including or excluding the supraclavicular fossa and axilla. Standard fractionation (1.8 to 3.0 Gray (Gy) per fraction) had to be used, delivering 40 to 61 Gy at the reference point. It could include a boost (using electrons, interstitial therapy or external beam) or new techniques. </p> </section> <section id="CD005212-sec-0033"> <h4 class="title">Types of outcome measures</h4> <section id="CD005212-sec-0034"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD005212-list-0002"> <li> <p>Local recurrence in the ipsilateral (i.e. same) breast and cause‐specific mortality. We defined local recurrence as including recurrence in the ipsilateral breast (i.e. the breast in which cancer had been diagnosed), the skin and parenchyma. </p> </li> </ul> </p> </section> <section id="CD005212-sec-0035"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD005212-list-0003"> <li> <p>Overall survival.</p> </li> <li> <p>Distant metastases (in isolation or at the same time as local recurrence).</p> </li> <li> <p>Relapse‐free survival.</p> </li> <li> <p>Subsequent mastectomy.</p> </li> <li> <p>Harms, including acute and late effects of RT‐ and CT‐related toxicity.</p> </li> <li> <p>Ability to deliver the prescribed dose of CT and ability to deliver the prescribed dose of RT. We set an arbitrary threshold of 80% when assessing the ability to deliver the prescribed dose of CT or RT. </p> </li> <li> <p>Costs.</p> </li> <li> <p>Quality of life (QoL).</p> </li> <li> <p>Consumer preference.</p> </li> </ul> </p> </section> </section> </section> <section id="CD005212-sec-0036"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD005212-sec-0037"> <h4 class="title">Electronic searches</h4> <p>For the original review published in 2006, we searched the Cochrane Breast Cancer Group's Specialised Register. Details of the search strategy used by the Group to create this register and the procedure used to code the references are described in the Group's module in <i>The Cochrane Library</i>. We extracted studies coded with each of the three terms 'early', 'chemotherapy' and 'radiotherapy' for consideration. We also conducted electronic searches of CENTRAL (Issue 4, 2005), MEDLINE, CINAHL Current Contents and the Science Citation Index. </p> <p>For the 2011 review update, a further search on the Cochrane Breast Cancer Group's Specialised Register on 20 May 2011, MEDLINE (14 December 2011; see <a href="./appendices#CD005212-sec-0079">Appendix 1</a> for the search strategy), EMBASE (20 May 2011; see <a href="./appendices#CD005212-sec-0080">Appendix 2</a> for the search strategy), Current Contents (December 2011), CINAHL (20 January 2012; see <a href="./appendices#CD005212-sec-0081">Appendix 3</a>) and Science Citation Index (12 March 2012; see <a href="./appendices#CD005212-sec-0082">Appendix 4</a>). </p> <p>We also searched registers of ongoing clinical trials for the 2011 update. These included the US clinical trials registry (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>), the International Standard Randomised Controlled Trial Number Register (<a href="http://www.controlled-trials.com/isrctn" target="_blank">www.controlled‐trials.com/isrctn</a>) and the UKCCR National Register of Cancer Trials and the WHO International Clinical Trials Registry Platform (20 May 2011; see <a href="./appendices#CD005212-sec-0083">Appendix 5</a> for the search strategy). </p> <p>We also searched other sources of unpublished trials (Greynet, National Research Register) on 25 January 2012 and we contacted researchers to ask if they were aware of any other trials on this topic. </p> <p>We checked for additional citations in eligible articles.</p> <p>No language restrictions were employed.</p> </section> <section id="CD005212-sec-0038"> <h4 class="title">Searching other resources</h4> <p>We handsearched a number of conference proceedings and published abstracts. These included: 2001 Adjuvant Therapy for Primary Breast Cancer International Conference; Era of Hope, Department of Defence Breast Cancer Research Program Meeting; 2001 and 2003: Primary Therapy of Early Breast Cancer; 6th and 7th Nottingham International Breast Cancer Meeting Conference Report; 23rd and 24th Congress of the International Association for Breast Cancer Research; 3rd and 4th Perspectives in Breast Cancer Conference Report; 26th and 27th Annual San Antonio Breast Cancer Symposium; 4th European Breast Cancer Conference; 94th and 95th American Association of Cancer Research; American Society for Clinical Oncology (1995 to 2005); European Society for Therapeutic and Radiation Oncology (2000 to 2004); 5th and 6th Milan Breast Cancer Conference; Australian Breast Cancer Conference (2004); 27th and 28th Annual Symposium of the American Society of Breast Disease; CDC Cancer Conference (2003); British Cancer Meeting Report; Canadian Breast Cancer Research Conference: Reasons for Hope. </p> </section> </section> <section id="CD005212-sec-0039"> <h3 class="title" id="CD005212-sec-0039">Data collection and analysis</h3> <section id="CD005212-sec-0040"> <h4 class="title">Selection of studies</h4> <p>All three review authors (BH, ML and DF) checked the titles and abstracts retrieved by all searches. Each author assessed independently the full text of the studies we thought might be relevant to the review, resolving differences through discussion. We assessed trials with the results masked. In cases where only limited data, information on study methods or both was reported, we requested further information from the authors of the original articles. </p> </section> <section id="CD005212-sec-0041"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (BH and ML) performed data extraction, with disagreements resolved by discussion. We contacted the original authors for data from unpublished trials or published trials that did not report data needed for this review. Data were entered into Reference Manager software (<a href="./references#CD005212-bbs2-0069" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011. ">RevMan 2011</a>) for analyses. Where possible, we extracted data on tumour stage, nodal status (pathological), margin status, receptor status, hormonal manipulation, treatment allocation and surgery performed. The information we extracted on RT and CT included time from randomisation to the start of RT and CT, duration of CT, duration of RT, radiation dose and dose per fraction. We extracted outcome data for local recurrence, distant metastases, deaths (cause‐specific and all‐cause), treatment‐related toxicity (including that related to acute and late effects of RT and CT), costs of treatment, consumer preference and quality of life. </p> </section> <section id="CD005212-sec-0042"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (BH and ML) judged and graded each RCT by using the Cochrane's 'Risk of bias' assessment tool as outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005212-bbs2-0052" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). Grades given by each author were compared and disagreements were resolved by discussion. The tool contains six domains and each domain was assigned a judgement related to the risk of bias. A judgement of 'low' indicated a low risk of bias, 'high' indicated a high risk of bias and 'unclear' indicated an unknown risk of bias. The six domains were: </p> <p> <ol id="CD005212-list-0004"> <li> <p>sequence generation;</p> </li> <li> <p>allocation concealment;</p> </li> <li> <p>blinding of participants, personnel and outcome assessors;</p> </li> <li> <p>incomplete outcome data;</p> </li> <li> <p>selective outcome reporting; and</p> </li> <li> <p>other sources of bias.</p> </li> </ol> </p> <p>The judgements of these domains for each RCT were reported in the 'Risk of bias' tables.</p> </section> <section id="CD005212-sec-0043"> <h4 class="title">Measures of treatment effect</h4> <p>Dichotomous results (e.g. acute and late toxicity, cosmesis) were presented as ORs with 95% CI (<a href="./references#CD005212-bbs2-0043" title="DeeksJJ , Higgins , JPT , AltmanDG , editors. Analysing and presenting results. In: AldersonP , GreenS , HigginsJPT editor(s). Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]; Section 8. The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley &amp; Sons Ltd, 2003. ">Deeks 2003</a>). We used Mantel‐Haenszel methods to calculate pooled results (<a href="./references#CD005212-bbs2-0048" title="GreenlandS , RobbinsJ . Estimation of a common effect parameter from sparse follow‐up data. Biometrics1985;48:159‐63. ">Greenland 1985</a>; <a href="./references#CD005212-bbs2-0062" title="MantelN , HaenszelWH . Statistical aspects of the analysis of data for retrospective studies of disease. Journal of the National Cancer Institute1959;22:719‐48. ">Mantel 1959</a>). </p> <p>Time‐to‐event outcomes (e.g. local recurrence‐free survival) were presented as hazard ratios (HR). </p> </section> <section id="CD005212-sec-0044"> <h4 class="title">Dealing with missing data</h4> <p>We contacted the original authors for data from unpublished trials or published trials that did not report data needed for this review. </p> </section> <section id="CD005212-sec-0045"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity both visually and statistically using the Chi<sup>2</sup> test of heterogeneity (<a href="./references#CD005212-bbs2-0032" title="AltmanDG . Practical Statistics for Medical Research. London: Chapman and Hall, 1992. ">Altman 1992</a>; <a href="./references#CD005212-bbs2-0074" title="WalkerAM , Martin‐MorenoJM , ArtalejoFR . Odd man out: a graphical approach to meta‐analysis. American Journal of Public Health1988;78:961‐6. ">Walker 1988</a>). We did not identify significant heterogeneity among the results of the trials in the current analysis, but if heterogeneity is identified in updates of this review, the reasons for it will be explored and we will make a cautious attempt to explain it. </p> </section> <section id="CD005212-sec-0046"> <h4 class="title">Data synthesis</h4> <p>We used the intention‐to‐treat principle in analysing data from the trials and determined a weighted average treatment effect by using the fixed‐effect model to combine results (<a href="./references#CD005212-bbs2-0062" title="MantelN , HaenszelWH . Statistical aspects of the analysis of data for retrospective studies of disease. Journal of the National Cancer Institute1959;22:719‐48. ">Mantel 1959</a>) in Review Manager software (<a href="./references#CD005212-bbs2-0069" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011. ">RevMan 2011</a>). </p> <p>For the comparisons of concurrent versus sequential CT and RT, raw data were not reported and therefore the HR and associated statistics were calculated, where necessary, using an Excel spreadsheet developed by the Matthew Sydes (Cancer Division) in collaboration with the Meta‐analysis Group of the MRC Clinical Trials Unit, London (<a href="./references#CD005212-bbs2-0071" title="TierneyJT , StewartLA , GhersiD , BurdettS , SydesMR . Practical methods for incorporating summary time‐to‐event data into meta‐analysis. Trials2007;8(16):1‐16. ">Sydes</a>). This spreadsheet was used for the end points of overall survival and relapse‐free survival (<a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>; <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>). </p> <p>Similarly, for the comparison of RT then CT versus CT then RT, raw data were not reported and therefore the HR and associated statistics were calculated, where necessary, using an Excel spreadsheet developed by the Matthew Sydes (Cancer Division) in collaboration with the Meta‐analysis Group of the MRC Clinical Trials Unit, London (<a href="./references#CD005212-bbs2-0071" title="TierneyJT , StewartLA , GhersiD , BurdettS , SydesMR . Practical methods for incorporating summary time‐to‐event data into meta‐analysis. Trials2007;8(16):1‐16. ">Sydes</a>). In this case, the spreadsheet was used for the end points of overall survival, distant metastases and relapse‐free survival (<a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>). </p> <p>Acute toxicity was dichotomised and we reported the OR with 95% CI. The authors used a four‐point scale to report cosmesis (see <a href="#CD005212-tbl-0001">Table 1</a>) and reported the proportion of women with excellent cosmetic results (<a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>). </p> <div class="table" id="CD005212-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Harris's classification</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cosmetic score</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Excellent</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Good</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fair</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> </tr> </tbody> </table> </div> <p>For late toxicity (breast atrophy, breast fibrosis, telangiectasia, lymphoedema and cosmesis), the data were dichotomised and we reported the Grade III/IV toxicity on the LENT‐SOMA scale (see <a href="#CD005212-tbl-0002">Table 2</a>). For pigmentation (not included in LENT‐SOMA) we reported those who had poor or very poor pigmentation (see <a href="#CD005212-tbl-0003">Table 3</a>). Late cosmetic toxicity was dichotomised and we reported the proportion who had poor or very poor cosmesis on a five‐point scale (see <a href="#CD005212-tbl-0004">Table 4</a>). </p> <div class="table" id="CD005212-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">LENT/SOMA scoring scale</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Type of outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Category</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade 1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade 2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade 4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Subjective</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Occasional and minimal, hypersensation, pruritus</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intermittent and tolerable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Persistent and intense</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Refractory and excruciating</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Objective</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oedema</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Asymptomatic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Symptomatic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Secondary dysfunction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fibrosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barely palpable, increased density</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Definite increased density and firmness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very marked increased density, retraction and fixation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Telangiectasia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 1 cm<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 to 4 cm<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 4 cm<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lymphoedema</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 to 4 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 4 to 6 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 6 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Useless arm</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Atrophy/retraction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10% to 25%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 25% to 40%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 40% to 75%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Whole breast</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ulcer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Epidermal only ≤ 1 cm<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dermal &gt; 1 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Subcutaneous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bone exposed/necrosis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Occasional, non‐narcotic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Regular narcotic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Regular narcotic medical intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Surgical intervention</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oedema</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Medical intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Surgical intervention/mastectomy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lymphoedema arm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elevate arm, elastic stocking</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Compression wrapping, intensive physiotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Surgical intervention/amputation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Atrophy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Surgical intervention/mastectomy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ulcer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Medical intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Surgical intervention/debridement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Surgical intervention/mastectomy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Analytic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Photographic assessment of skin change</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes/no</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Date:</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tape measurement of breast size and arm diameter</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes/no</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Date:</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mammogram assessment of skin thickness and density</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes/no</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Date:</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes/no</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Date: computer tomography/magnetic resonance imaging assessment of size, fat atrophy, fibrosis </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes/no</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Date:</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD005212-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Pigmentation scoring scale</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pigmentation scoring scale</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Excellent</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Good</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very poor</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD005212-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Harris's classification modified by Beadle cosmetic scale</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cosmetic score</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Excellent</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Good</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acceptable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very poor</p> </td> </tr> </tbody> </table> </div> <p>If quality of life scores are available for future updates, we will obtain the standard deviation and the mean to analyse the data. If different scales are reported in the trials, we will use the standardised mean difference to summarise data (<a href="./references#CD005212-bbs2-0043" title="DeeksJJ , Higgins , JPT , AltmanDG , editors. Analysing and presenting results. In: AldersonP , GreenS , HigginsJPT editor(s). Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]; Section 8. The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley &amp; Sons Ltd, 2003. ">Deeks 2003</a>). </p> </section> <section id="CD005212-sec-0047"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>The current version of this review does not include any subgroup analyses because of the lack of data. However, if sufficient data become available in future updates, we may perform subgroup analyses to investigate whether the effects of different sequences of RT and CT differ depending upon nodal status, margin status, receptor status, hormonal manipulation and tumour stage. </p> </section> <section id="CD005212-sec-0048"> <h4 class="title">Sensitivity analysis</h4> <p>Sufficient data were not available to perform a sensitivity analysis. In future updates, if adequate data are available, we would perform sensitivity analyses to assess the robustness of our results by repeating the analysis with the following adjustments: </p> <p> <ol id="CD005212-list-0005"> <li> <p>repeating the analysis excluding studies with high risk of bias;</p> </li> <li> <p>repeating the analysis each time excluding unpublished trials.</p> </li> </ol> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD005212-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD005212-sec-0049"></div> <section id="CD005212-sec-0050"> <h3 class="title">Description of studies</h3> <section id="CD005212-sec-0051"> <h4 class="title">Results of the search</h4> <p>After screening the titles and abstracts retrieved electronically and by handsearching, we identified 441 reports for possible inclusion in this review. Further screening of these reduced the number to 45 reports and, where possible, we obtained the full articles for these. The results presented in these articles were masked and the remaining text was assessed by two review authors (BH and ML). This revealed that 19 of the reports did not relate to RCTs ( <a href="./references#CD005212-bbs2-0006" title="BellonJR , ShulmanLN , ComeSE , LiX , GelmanRS , SilverBJ , et al. A prospective study of concurrent cyclophosphamide/methotrexate/5‐fluorouracil and reduced‐dose radiotherapy in patients with early‐stage breast carcinoma. Cancer2004;100(7):1358‐64. ">Bellon 2004</a>; <a href="./references#CD005212-bbs2-0008" title="BuzdarAU , KauSW , SmithTL , AmesF , SingletaryE , StromE , et al. The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer. Cancer1993;71(11):3680‐7. ">Buzdar 1993</a>; <a href="./references#CD005212-bbs2-0009" title="CakirS , GurselB , MeydanD , YildizL . The sequencing of radiation therapy and chemotherapy after mastectomy in premenopausal women with breast cancer. Japanese Journal of Clinical Oncology2003;33(11):563‐9. ">Cakir 2003</a>; <a href="./references#CD005212-bbs2-0010" title="DenhamJW , HailtonCS , ChristieD , O'BrienM , BonaventuraA , StewartJF , et al. Simultaneous adjuvant radiation therapy and chemotherapy in high‐risk breast cancer toxicity and dose modification: a Trans‐Tasman Radiation Oncology Group multi‐institution study. International Journal of Radiation Oncology Biology Physics1995;31(2):305‐13. ">Denham 1995</a>; <a href="./references#CD005212-bbs2-0012" title="DubeyA , RechtA , ComeSE , GelmanRS , SilverB , HarrisJR , et al. Concurrent CMF and radiation therapy for early stage breast cancer: results of a pilot study. International Journal of Radiation Oncology Biology Physics1999;45(4):877‐84. ">Dubey 1999</a>; <a href="./references#CD005212-bbs2-0013" title="FaulC , JacobH , Karasek‐GersztenK , KunschnerA , VogelV , FlickingerJ . Concurrent CMF chemotherapy and radiation therapy in early breast cancer: tolerance and cosmesis (Meeting abstract). Proceedings of the annual meeting of the American Society of Clinical Oncology. 1998. ">Faul 1998</a>; <a href="./references#CD005212-bbs2-0014" title="FaulC , BrufskyA , GersztenK , FlickingerJ , KunschnerA , JacobH , et al. Concurrent sequencing of full‐dose CMF chemotherapy and radiation therapy in early breast cancer has no effect on treatment delivery. European Journal of Cancer2003;39:763‐8. ">Faul 2003</a>; <a href="./references#CD005212-bbs2-0015" title="FietsWE , vanHelvoirtRP , NortierJWR , van derTweelI , StruikmansH . Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients: a prospective, comparative, non‐randomised study. European Journal of Cancer2003;39:1081‐8. ">Fiets 2003</a>; <a href="./references#CD005212-bbs2-0016" title="GarciaPJL , TalaveraHMC , RodriguezRP , CuetoLDGJ , MartinLI , MoyaOJ , et al. Adjuvant QT and RT in breast cancer. Influence of the therapeutic sequence [Irradiacion Y quimioterapia adyuvante en cancer de mama. Influencia de la secuencia terapeutica en el control a largo plazo de la enfermedad]. Oncologia1996;19(1):52‐60. ">Garcia 1996</a>; <a href="./references#CD005212-bbs2-0017" title="HartsellWR , RecineDC , GriemKL , MurthyAK . Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence. Cancer1995;76(12):2497‐503. ">Hartsell 1995</a>; <a href="./references#CD005212-bbs2-0018" title="HasbiniA , LePechouxC , RocheB , PignolJP , ZelekL , AbdulkarimB , et al. Alternating chemotherapy and hyperfractionated accelerated radiotherapy in non‐metastatic inflammatory breast cancer [Radiothérapie hyperfractionnée alternée une chimiothérapie dans le cancer du sein inflammatoire non métastatique]. Cancer/Radiothérapie2000;4:265‐73. ">Hasbini 2000</a>; <a href="./references#CD005212-bbs2-0019" title="IsaacN , PanzarellaT , LauA , MayersC , KirkbrideP , TannockIF , et al. Concurrent cyclophosphamide, methotrexate, and 5‐fluorouracil chemotherapy and radiotherapy for breast carcinoma. Cancer2002;95(4):696‐702. ">Isaac 2002</a>; <a href="./references#CD005212-bbs2-0021" title="LambD , AtkinsonC , JosephD , O'BrienP , AcklandS , BonaventuraA , et al. Simultaneous adjuvant radiotherapy and chemotherapy for stage I and II breast cancer. Australasian Radiology1999;43:220‐6. ">Lamb 1999</a>; <a href="./references#CD005212-bbs2-0022" title="LeonardCE , WoodME , ZhenB , RankinJ , WaitzDa , NortonL , et al. Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control?. Journal of Clinical Oncology1995;13(12):2906‐15. ">Leonard 1995</a>; <a href="./references#CD005212-bbs2-0023" title="RechtA , ComeSE , GelmanRS , GoldsteinM , TishlerS , GoreSM , et al. Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early stage, node positive breast cancer: sequencing, timing and outcome. Journal of Clinical Oncology1991;9(9):1662‐7. ">Recht 1991</a>; <a href="./references#CD005212-bbs2-0025" title="RubensRD , SextonS , TongD , WinterPJ , KnightRK , HaywardJL . Combined chemotherapy and radiotherapy for locally advanced breast cancer. European Journal of Cancer1980;16:351‐6. ">Rubens 1980</a>; <a href="./references#CD005212-bbs2-0026" title="SauerR , MartusD . Sequencing of chemotherapy and radiotherapy following breast‐preserving treatment of breast carcinoma. Strahlentherapie und Onkologie1996;172(9):516‐7. ">Sauer 1996</a>; <a href="./references#CD005212-bbs2-0027" title="StemmerSM , RizelS , HardanI , AdamoA , NeumannA , GoffmanJ , et al. The role of irradiation of the internal mammary lymph nodes in high risk stage II to IIIa breast cancer patients after high‐dose chemotherapy: a prospective sequential non‐randomized study. Journal of Clinical Oncology2003;21(14):2713‐8. ">Stemmer 2003</a>; <a href="./references#CD005212-bbs2-0030" title="ZambettiM , OrianaS , QuattroneP , VerderioP , TerenzianaM , ZucaliR , et al. Combined sequential approach in locally advanced breast cancer. Annals of Oncology1999;10:305‐10. ">Zambetti 1999</a>) and the treatments investigated in six were not eligible for this review (<a href="./references#CD005212-bbs2-0004" title="AssersohnL , PowlesTJ , AshleyS , NashAG , NealAJ , SacksN , et al. Local relapse in primary breast cancer patients with excised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy. Annals of Oncology1999;10:1451‐5. ">Assersohn 1999</a>; <a href="./references#CD005212-bbs2-0005" title="BellantoneR , LombardiCP , CefaroGA , NardoneL , RossiS , MinelliS , et al. CMF and radiotherapy in the primary treatment of operable breast cancer: preliminary results of a phase II pilot study. Journal of Surgical Oncology1998;68:48‐50. ">Bellantone 1998</a>; <a href="./references#CD005212-bbs2-0007" title="BlomqvistC , TiusanenK , ElomaaI , RissanenP , HietanenT , HeinonenE , et al. The combination of radiotherapy, adjuvant chemotherapy cyclophosphamide‐doxorubicin‐ftorafur) and tamoxifen in stage II breast cancer. Long‐term follow‐up results of a randomised trial. British Journal of Cancer1992;66:1171‐6. ">Blomqvist 1992</a>; <a href="./references#CD005212-bbs2-0011" title="DonatoV , MonacoA , MessinaF , DeSanctisV , MessineoD , BanellisE , et al. Local recurrence in breast cancer after conservative surgery: timing of radiotherapy and sequencing of chemotherapy. Anticancer Research2004;24(2C):1303‐6. ">Donato 2004</a>; <a href="./references#CD005212-bbs2-0028" title="WallgrenA , BernierJ , GelberRD , GoldhirschA , RonacadinM , JosephD , et al. for the International Breast Cancer Study Group. Timing of radiotherapy and chemotherapy following breast‐conserving surgery for patients with node‐positive breast cancer. International Journal of Radiation Oncology Biology Physics1996;35(4):649‐9. ">Wallgren 1996</a>; <a href="./references#CD005212-bbs2-0029" title="WarnerNJ , RanganAM , LanglandsAO , BoyagesJ . Effect of concurrently chemotherapy and radiotherapy on breast cosmesis: a study of patients' perceptions. The Breast1998;7:131‐6. ">Warner 1998</a>). One study investigated different sequences of therapy but was confounded (and, therefore, ineligible) because the CT regimens were different in the two randomised groups (<a href="./references#CD005212-bbs2-0024" title="RouesseJ , CvitkovicF , DeLalandeB , SerinD , GraicY , CombeM , et al. Concomitant or sequential chemo‐radiotherapy (CRT) in operable breast cancer. Final results of a French multicentric phase III study. Breast Cancer Research and Treatment2002;76(Suppl 1):S160. ">Rouesse 2002</a>). Eighteen reports did relate to four studies that appeared to meet our inclusion criteria (<a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>; Arcangeli 2004 (see <a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>); Bellon 2002 (see <a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>); <a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>; <a href="./references#CD005212-bbs2-0035" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiotherapy for patients with early stage breast cancer: updated results of a prospective randomized trial [abstract]. International Journal of Radiation Oncology Biology Physics2001;51Suppl 3(2a):2‐3. ">Bellon 2001</a>; <a href="./references#CD005212-bbs2-0038" title="CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al of the ACROSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. ">Calais 1998a</a>; <a href="./references#CD005212-bbs2-0039" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapir concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. ">Calais 1998b</a>; <a href="./references#CD005212-bbs2-0040" title="CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International Journal of Radiation Oncology, Biology, Physics2002;54 Suppl 1(1):57‐8. ">Calais 2002</a>; <a href="./references#CD005212-bbs2-0041" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer [Irradiation et chimiothérapie concomitanteaprès chirurgie pour cancer du sein]. Cancer/Radiothérapie2004;8:39‐47. ">Calais 2004</a>; Fernando 2011 (see <a href="./references#CD005212-bbs2-0031" title="FernandoI N , BowdenSJ , FoxRP , GrieveR , BruntAM , AgrawalRK , et al. Effect of synchronous chemo‐radiation on quality of life: results from the SECRAB trial. European Journal of Cancer2011;47:S366. ISRCTN84214355 . Phase III randomised study of synchronous versus sequential adjuvant chemotherapy and radiotherapy in women with early stage breast cancer, 2012. www.ukctg.nihr.ac.uk/trialdetails/ISRCTN84214355. (accessed 20 November 2012). ">SECRAB</a>); ISRCTN84214355 (see <a href="./references#CD005212-bbs2-0031" title="FernandoI N , BowdenSJ , FoxRP , GrieveR , BruntAM , AgrawalRK , et al. Effect of synchronous chemo‐radiation on quality of life: results from the SECRAB trial. European Journal of Cancer2011;47:S366. ISRCTN84214355 . Phase III randomised study of synchronous versus sequential adjuvant chemotherapy and radiotherapy in women with early stage breast cancer, 2012. www.ukctg.nihr.ac.uk/trialdetails/ISRCTN84214355. (accessed 20 November 2012). ">SECRAB</a>); <a href="./references#CD005212-bbs2-0049" title="HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology, Biology, Physics1999;45(1):69‐72. ">Hardenbergh 1999</a>; <a href="./references#CD005212-bbs2-0066" title="PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL , ArcangeliG . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Pinnaro 2011</a>; <a href="./references#CD005212-bbs2-0068" title="RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Recht 1996</a>; Toledano 2006a (see <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>); Toledano 2006b (see <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>); Toledano 2007a (see <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>); Toledano 2007b (see <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>)). One study (<a href="./references#CD005212-bbs2-0031" title="FernandoI N , BowdenSJ , FoxRP , GrieveR , BruntAM , AgrawalRK , et al. Effect of synchronous chemo‐radiation on quality of life: results from the SECRAB trial. European Journal of Cancer2011;47:S366. ISRCTN84214355 . Phase III randomised study of synchronous versus sequential adjuvant chemotherapy and radiotherapy in women with early stage breast cancer, 2012. www.ukctg.nihr.ac.uk/trialdetails/ISRCTN84214355. (accessed 20 November 2012). ">SECRAB</a>) has completed accrual, but has only been reported in abstract form (<a href="#CD005212-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD005212-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram (updated search results to 14 December 2011)." data-id="CD005212-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram (updated search results to 14 December 2011).</p> </div> </div> </div> <p>The eighteen reports that met the inclusion criteria related to three separate studies because some of the trials had published their results at different times, with different periods of follow‐up. In these cases we used the most recent publication as the main source for this review, supplementing this with information from earlier reports if necessary. Thus, for <a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>, the main source was the <a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a> article, with four other publications found for this trial (<a href="./references#CD005212-bbs2-0035" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiotherapy for patients with early stage breast cancer: updated results of a prospective randomized trial [abstract]. International Journal of Radiation Oncology Biology Physics2001;51Suppl 3(2a):2‐3. ">Bellon 2001</a>; Bellon 2002; <a href="./references#CD005212-bbs2-0049" title="HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology, Biology, Physics1999;45(1):69‐72. ">Hardenbergh 1999</a>; <a href="./references#CD005212-bbs2-0068" title="RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Recht 1996</a>). Similarly, for <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>, our primary source for data extraction was <a href="./references#CD005212-bbs2-0041" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer [Irradiation et chimiothérapie concomitanteaprès chirurgie pour cancer du sein]. Cancer/Radiothérapie2004;8:39‐47. ">Calais 2004</a>, with some information also available in seven other publications (<a href="./references#CD005212-bbs2-0038" title="CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al of the ACROSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. ">Calais 1998a</a>; <a href="./references#CD005212-bbs2-0039" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapir concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. ">Calais 1998b</a>; <a href="./references#CD005212-bbs2-0040" title="CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International Journal of Radiation Oncology, Biology, Physics2002;54 Suppl 1(1):57‐8. ">Calais 2002</a>; Toledano 2006a, Toledano 2006b; Toledano 2007a; Toledano 2007b). For <a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>, our primary source was <a href="./references#CD005212-bbs2-0066" title="PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL , ArcangeliG . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Pinnaro 2011</a>, with some information available from <a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>. </p> <p>One report (<a href="./references#CD005212-bbs2-0039" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapir concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. ">Calais 1998b</a>) required translation from French to English, while another (<a href="./references#CD005212-bbs2-0016" title="GarciaPJL , TalaveraHMC , RodriguezRP , CuetoLDGJ , MartinLI , MoyaOJ , et al. Adjuvant QT and RT in breast cancer. Influence of the therapeutic sequence [Irradiacion Y quimioterapia adyuvante en cancer de mama. Influencia de la secuencia terapeutica en el control a largo plazo de la enfermedad]. Oncologia1996;19(1):52‐60. ">Garcia 1996</a>) required translation from Spanish to English. </p> <p>Of the three authors we contacted, two provided us with additional data on their studies (<a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>; <a href="./references#CD005212-bbs2-0024" title="RouesseJ , CvitkovicF , DeLalandeB , SerinD , GraicY , CombeM , et al. Concomitant or sequential chemo‐radiotherapy (CRT) in operable breast cancer. Final results of a French multicentric phase III study. Breast Cancer Research and Treatment2002;76(Suppl 1):S160. ">Rouesse 2002</a>). We are awaiting further information from one (<a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>), as of 18/03/13, this had not been provided. </p> </section> <section id="CD005212-sec-0052"> <h4 class="title">Included studies</h4> <section id="CD005212-sec-0053"> <h5 class="title">Participants, follow‐up and treatment regimens</h5> <p>The three RCTs, included in the updated version of this review, randomised 1166 patients. Two studies (<a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>; <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>), with 922 patients, compared concurrent CT and RT with sequential administration of CT before RT. <a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a> initially reported results at 65 months' follow‐up then again after median follow‐up of 111 months. <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a> reported at 60 months' median follow‐up, but late effects were reported at a median of 6.7 years' follow‐up. First‐generation chemotherapeutic agents were used (i.e. no anthracyclines or taxanes). </p> </section> <section id="CD005212-sec-0054"> <h5 class="title">Delay to start of radiotherapy</h5> <p>In the two studies (<a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>; <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>) that compared concurrent CT and RT with sequential administration of CT before RT, RT was started by a maximum of 161 days (about 5.3 months) in <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a> and by 210 days (seven months) in <a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>. In <a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>, which compared RT followed by CT to CT followed by RT, RT started by 84 days (about 2.8 months) after surgery. </p> <p>The third RCT (<a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>) compared RT followed by CT to CT followed by RT in 244 patients. <a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a> reported at a median follow‐up of 135 months. More information on the three included studies can be found in the '<a href="./references#CD005212-sec-0093" title="">Characteristics of included studies</a>' table. Anthracyclines were used but not taxanes. </p> </section> <section id="CD005212-sec-0055"> <h5 class="title">Local recurrence</h5> <p>For the comparison of concurrent versus sequential CT and RT, local recurrence was reported in <a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>, but loco‐regional recurrence was reported in <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>, so we were not able to combine the results for this outcome. For the comparison of RT then CT versus CT then RT, local recurrence was reported as first‐event data and we have contacted the authors (<a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>) in order to clarify this but await their reply. </p> </section> <section id="CD005212-sec-0056"> <h5 class="title">Toxicity</h5> <p>Acute toxicity was assessed at one month after completion of RT (<a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>) and was reported for 30% (214/716) of women randomised. Grade III/IV acute toxicity was reported (however, the scoring system was not given; <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>). Acute haematological and skin toxicity was reported using the common toxicity criteria (CTC) acute scoring system (<a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>). </p> <p>Late toxicity was assessed in <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a> and scored prospectively at a median follow‐up of 6.7 years in 29% (214/716) of those women randomised. Two hundred and ninety‐seven women from the five larger participating institutions were asked to report for a follow‐up examination and 72% (214/297) of these women were evaluated for late toxicity. Late toxicity was scored using the Late Effects Normal Tissue Task Force (LENT)/Subjective, Objective, Management, Analytic (SOMA) scale (validated scale) by an observer blinded to the treatment arm (see <a href="#CD005212-tbl-0002">Table 2</a>). A personal five‐point scoring system was used to score pigmentation (not included in the LENT/SOMA scale; see <a href="#CD005212-tbl-0003">Table 3</a>). Late toxicity was scored as a single event at last follow‐up. Breast oedema was defined as "permanent swelling with an increased volume of the breast" and fibrosis was detected by palpation, in comparison to the untreated breast. Oedema was reported when the measurements differed. Cardiac events were defined as myocardial infarction or clinical evidence of congestive cardiac failure. Symptomatic radiation pneumonitis was characterised by a cough, fever and shortness of breath that occurred two to nine months after completing RT. </p> <p>In <a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>, cardiac toxicity was assessed in 231/244 (95%) women at a median follow‐up of 53 months. Cardiac events were defined as myocardial infarction or congestive cardiac failure. Late toxicity data were extracted from medical records and not prospectively collected. Cellulitis was defined as the "inflammation of the breast unresponsive to antibiotics" and lymphoedema was recorded if there was a description of a "swollen or oedematous arm in the treatment record" (no measurements were made at baseline or of the contralateral arm). Brachial plexopathy was evaluated only in those women who had regional nodal RT. </p> </section> <section id="CD005212-sec-0057"> <h5 class="title">Cosmesis</h5> <p>For the comparison of concurrent versus sequential CT and RT, cosmetic outcome was reported for 29% (214/716) of women after a median of 6.7 years' follow‐up. Seventy‐two per cent (214/297) of women from the five larger participating institutions who were asked to report for a follow‐up examination were evaluated for cosmesis. The primary reason for refusal was a reluctance to attend the hospital for clinical assessments. In <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>, cosmesis was evaluated both by the patient (using a five‐point scale; <a href="./references#CD005212-bbs2-0053" title="HoellerU , KuhlmeyA , BajrovicA , GraderK , BergerJ , TribiusS , et al. Cosmesis from the patient's and the doctor's view. International Journal of Radiation Oncology, Biology, Physics2003;57:345‐54. ">Hoeller 2003</a>) and physician blinded to treatment allocation. Physician‐assessed cosmesis was scored thus by an overall cosmetic satisfaction score based on the comparison between the treated and untreated breast (see <a href="#CD005212-tbl-0005">Table 5</a>) using "Harris's classification modified by Beadle" (<a href="./references#CD005212-bbs2-0034" title="BeadleGF , SilverB , BotnickL , HellmanS , HarrisJR . Cosmetic results following primary breast irradiation for early breast cancer. Cancer1984;54:2911‐8. ">Beadle 1984</a>; <a href="./references#CD005212-bbs2-0050" title="HarrisJR , LeveneMB , SvenssonG , HellmanS . Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. International Journal of Radiation Oncology, Biology, Physics1979;5(2):257‐61. ">Harris 1979</a>; see <a href="#CD005212-tbl-0004">Table 4</a>). The second score was derived using a detailed definition of how to score cosmesis satisfaction (<a href="./references#CD005212-bbs2-0046" title="FehlauerF , TribiusS , HöllerU , RadesD , KuhlmeyA , BajrovicA , et al. Long‐term radiation sequelae after breast‐conserving therapy in women with early‐stage breast cancer: an observational study using the LENT‐SOMA scoring system. International Journal of Radiation Oncology, Biology, Physics2003;55:651‐8. ">Fehlauer 2003</a>). To lessen inter‐observer variability, two observers examined 40 patients and the ratings were reproducible. There was "fair correlation" reported between the patient's and physician's assessment of cosmesis. The two methods of scoring cosmetic outcome by physicians were reported to be concordant (<a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>). </p> <div class="table" id="CD005212-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">LENT‐SOMA cosmetic outcome assessment</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Category</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Description</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very poor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very marked density, retraction, fixation and breast asymmetry 40% to 75%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Marked distortion of nipple, breast asymmetry 25% to 40%, marked contour difference, severe hyperpigmentation, severe oedema, marked mammillary deviation </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acceptable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate distortion of nipple, absent nipple‐areola complex, breast asymmetry 10% to 25%, telangiectasia, moderate hyperpigmentation, increased density and firmness, slight oedema, prominent scar with surrounding retraction/volume loss, moderate contour difference, moderate mammillary deviation </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Good</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Minimal differences between treated and untreated breast, slight distortion of nipple, mild hyperpigmentation, breast asymmetry &lt; 10%, mild telangiectasia </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very good</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treated breast looks almost identical to untreated breast, perfect symmetry, no visible distortion </p> </td> </tr> </tbody> </table> </div> <p>For the comparison of RT then CT versus CT then RT, cosmetic outcome was assessed in women without recurrence by a single radiation oncologist at 18 to 30 months after treatment (31% (76/244) of those women randomised; <a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>). The authors reported those in each group who had "excellent" cosmetic results (i.e. a virtual absence of changes due to treatment) on a four‐point scale (see <a href="#CD005212-tbl-0001">Table 1</a>; <a href="./references#CD005212-bbs2-0050" title="HarrisJR , LeveneMB , SvenssonG , HellmanS . Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. International Journal of Radiation Oncology, Biology, Physics1979;5(2):257‐61. ">Harris 1979</a>). Figures were derived from the percentages given in the text (<a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>). </p> </section> </section> <section id="CD005212-sec-0058"> <h4 class="title">Excluded studies</h4> <p>See <a href="#CD005212-sec-0058">Excluded studies</a> table. </p> </section> </section> <section id="CD005212-sec-0059"> <h3 class="title">Risk of bias in included studies</h3> <section id="CD005212-sec-0060"> <h4 class="title">Allocation</h4> <p>All three included studies were randomised (<a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>; <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>; <a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>). Details about the methods of randomisation were given in <a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a> where the authors stated a "balanced randomisation method" was used. It appears that the studies were truly randomised and had a low risk of selection bias. </p> </section> <section id="CD005212-sec-0061"> <h4 class="title">Blinding</h4> <p>In <a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>, blinding was not reported for the assessors of objective outcomes, if investigations such as mammograms or bone scans were performed at different times in the two groups, it may have introduced lead time bias. In <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>, for the subjective outcome of cosmesis, the assessor was blinded, which minimises the risk of bias for this outcome. Detection bias was less likely because there were pre‐specified intervals for clinical examination and investigations. Assessment of both late toxicity and cosmetic outcome were blinded, which minimises the risk of bias (<a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>). No mention was made of any blinding for either objective or subjective outcomes in <a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>, this means the findings are at risk of bias. </p> </section> <section id="CD005212-sec-0062"> <h4 class="title">Incomplete outcome data</h4> <p>All women randomised in the Arcangeli trial (<a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>) were included in the analysis. All women were analysed for the primary end point. A total of 214 of 647 (33%) women were included in the acute toxicity analysis in the ARCOSEIN trial (<a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>). The remainder of the analyses were performed on 96% and 98% of the included women. Both <a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a> and <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a> were thought to be at low risk of attrition bias. In <a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>, those women lost to follow‐up were described, and the trial authors comment that an intention‐to‐treat analysis was performed, but it can be seen from a table in the text that smaller numbers were available for evaluation at five years, which suggests there was a large amount of attrition in addition to the numbers lost to follow‐up reported  in each arm. This makes the Bellon trial at high risk of attrition bias (<a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>). </p> </section> <section id="CD005212-sec-0063"> <h4 class="title">Selective reporting</h4> <p>We did not review the protocols for any of the included trials. Cosmetic outcome has not been reported (although the trial authors indicated that they would in the methods) for <a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>. For <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a> and <a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>, the end points indicated in the text were all reported. The included studies are therefore at unclear risk of reporting bias (<a href="#CD005212-fig-0002">Figure 2</a>). </p> <div class="figure" id="CD005212-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD005212-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> </section> </section> <section id="CD005212-sec-0064"> <h3 class="title" id="CD005212-sec-0064">Effects of interventions</h3> <section id="CD005212-sec-0065"> <h4 class="title">Concurrent treatment versus chemotherapy followed by radiotherapy</h4> <p>For this comparison, first‐generation chemotherapeutic agents were used (i.e. no anthracyclines or taxanes). </p> <p>There were two studies, enrolling 853 women, in this comparison (<a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>; <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>). In the results presented, ratios of treatment effects are given such that an OR or HR of less than 1.0 would indicate a beneficial effect of concurrent treatment compared with sequential treatment. The results for each outcome are as follows. </p> <p> <ul id="CD005212-list-0006"> <li> <p>Local recurrence‐free survival (ipsilateral): both studies reported results for local recurrence. There were 14 such recurrences in 602 randomised women. There was no evidence to suggest that l ocal recurrence ‐free survival differed when concurrent CT/RT was compared with sequential at: </p> <ol id="CD005212-list-0007"> <li> <p>five‐year follow‐up: HR 0.96 (95% CI 0.14 to 6.82) (<a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>)(<a href="./references#CD005212-fig-0003" title="">Analysis 1.1</a>) or </p> </li> <li> <p>10‐year follow‐up: HR 1.05 (95% CI 0.30 to 3.62) (<a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>). As data were available from one trial, testing for heterogeneity was not appropriate (<a href="./references#CD005212-fig-0003" title="">Analysis 1.1</a>). </p> </li> </ol> </li> </ul> <ul id="CD005212-list-0008"> <li> <p>Cause‐specific survival: neither trial reported on this outcome.</p> </li> </ul> <ul id="CD005212-list-0009"> <li> <p>Overall survival: did not differ when concurrent CT/RT was compared with sequential at: </p> <ol id="CD005212-list-0010"> <li> <p>five year follow‐up: HR 0.97; 95% CI 0.83 to 1.13 (<a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>; <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>; <a href="./references#CD005212-fig-0006" title="">Analysis 1.4</a>). No heterogeneity was detected (I<sup>2</sup> = 0%, P = 0.92); </p> </li> <li> <p>median follow‐up of 111 months: HR 0.92; 95% CI 0.33 to 2.55 (<a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>). As data were available from one trial, testing for heterogeneity was not appropriate. </p> </li> </ol> </li> </ul> <ul id="CD005212-list-0011"> <li> <p>Metastasis‐free survival: 68/853 (8%) of the women in the two trials combined had distant metastases diagnosed. Metastasis‐free survival did not differ when concurrent CT/RT was compared with sequential at: </p> <ol id="CD005212-list-0012"> <li> <p>median follow‐up of 60 to 65 months: HR 0.86; 95% CI 0.60 to 1.24) (<a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>; <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>). No heterogeneity was detected (I<sup>2</sup> = 0%, P = 0.63); </p> </li> <li> <p>median follow‐up of 111 months: HR 0.57; 95% CI 0.20 to 1.62) (<a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>). As data were available from one trial, testing for heterogeneity was not appropriate. </p> </li> </ol> </li> </ul> <ul id="CD005212-list-0013"> <li> <p>Relapse‐free survival did not differ when concurrent CT/RT was compared with sequential at: </p> </li> </ul> <ul class="plain" id="CD005212-list-0014"> <li> <ol id="CD005212-list-0015"> <li> <p>median follow‐up of 50 to 65 months: HR 0.98; 95% CI 0.84 to 1.15 (<a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>; <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>). No heterogeneity was detected (I<sup>2</sup> = 0%, P = 0.75) (<a href="./references#CD005212-fig-0004" title="">Analysis 1.2</a>); </p> </li> <li> <p>median follow‐up of 111 months: HR 1.10; 95% CI 0.57 to 2.13 (<a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>) (<a href="./references#CD005212-fig-0004" title="">Analysis 1.2</a>). As data were available from one trial, testing for heterogeneity was not appropriate. </p> </li> </ol> </li> </ul> <ul id="CD005212-list-0016"> <li> <p>Mastectomy rate: no data.</p> </li> </ul> <ul id="CD005212-list-0017"> <li> <p>Harms and toxicity:</p> <ol id="CD005212-list-0018"> <li> <p>acute toxicity: the <a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a> report included the comment that acute toxicity was "mild in both groups, with infrequent moist desquamation in limited areas". The other study (<a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>), with 647 women, reported acute toxicity for 214/647(33%) women studied. Anaemia increased with concurrent CT/RT while nausea/vomiting and grade III/IV skin, infection or oesophagitis did not (<a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>; see <a href="#CD005212-tbl-0006">Table 6</a>); </p> </li> <li> <p>late toxicity: in <a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>, the authors indicated that late toxicity is currently being evaluated and will be reported separately. Late toxicity (including cosmesis) was reported in detail for a subgroup of 214/647 (33%) of women studied (<a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>). Telangiectasia and pigmentation were worse with concurrent CT/RT but atrophy, fibrosis and lymphoedema did not differ (<a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>; see <a href="#CD005212-tbl-0007">Table 7</a>). The women studied did not report worse cosmetic outcome for overall cosmesis, skin colour and scarring with concurrent CT/RT but the physician‐reported assessments indicated that cosmetic outcome was worse with concurrent CT/RT (<a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>; see <a href="#CD005212-tbl-0008">Table 8</a>); </p> </li> <li> <p>no cardiac events occurred in the <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a> trial; </p> </li> <li> <p>no woman had symptomatic pneumonitis in the <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a> trial; </p> </li> <li> <p>one woman in each treatment arm developed acute myelogenous leukaemia in the first 18 months after treatment in the <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a> trial. </p> </li> </ol> </li> </ul> </p> <div class="table" id="CD005212-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Acute toxicity: concurrent versus sequential</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Type of toxicity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Concurrent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sequential</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OR (95% CI)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Anaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111/352</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81/358</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.54 (1.10 to 2.15)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade II/IV skin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.21 (0.51 to 2.83)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade III/IV infection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.03 to 3.20)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade III/IV neutropenia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.71 (0.36 to 1.38)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nausea or vomiting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>235/352</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>248/343</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.77 (0.56 to 1.06)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade III/IV oesophagitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.20 (0.37 to 141.12)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval; OR: odds ratio.</p> </div> </div> <div class="table" id="CD005212-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Late Grade III/IV toxicity: concurrent versus sequential</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Toxicity type</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Concurrent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sequential</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OR (95% CI)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Atrophy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.09 (0.92 to 4.75)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Telangiectasia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.85 (1.37 to 10.87)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fibrosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.77 (0.77 to 247.54)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lymphoedema</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.02 (0.18 to 22.61)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pigmentation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12/105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.55 (1.73 to 106.19)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval; OR: odds ratio.</p> </div> </div> <div class="table" id="CD005212-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Late toxicity (cosmesis): concurrent versus sequential</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cosmetic outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Concurrent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sequential</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physician‐reported</p> <p>OR (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant‐reported</p> <p>OR (95% CI)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bad or very bad overall cosmesis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physician 43/107</p> <p>Participant 9/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physician 16/107</p> <p>Participant 8/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.82 (1.98 to 7.37)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.14 (0.42 to 3.07)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor/very poor skin colour</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physician 14/107</p> <p>Participant 3/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physician 1/107</p> <p>Participant 1/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.96 (2.06 to 123.68)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.06 (0.31 to 29.87)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor/very poor scar</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physician 24/107</p> <p>Participant 17/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physician 15/107</p> <p>Participant 12/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.77 (0.87 to 3.61)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.50 (0.68 to 3.31)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval; OR: odds ratio.</p> </div> </div> <p> <ul id="CD005212-list-0019"> <li> <p>Compliance:</p> <ol id="CD005212-list-0020"> <li> <p>ability to deliver the prescribed CT dose (compliance): our arbitrary threshold of the delivery of at least 80% of the prescribed CT was achieved for all women in both trials (OR 0.57; 95% CI 0.35 to 0.92) (<a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>; <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>) (<a href="./references#CD005212-fig-0005" title="">Analysis 1.3</a>); </p> </li> <li> <p>ability to deliver the prescribed RT dose (compliance): all patients in both randomised groups in the <a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a> trial received 100% of their planned RT, and there was no significant difference in the total dose delivered in both groups in the <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a> trial. </p> </li> </ol> </li> </ul> <ul id="CD005212-list-0021"> <li> <p>Costs: no data.</p> </li> </ul> <ul id="CD005212-list-0022"> <li> <p>QoL: no data.</p> </li> </ul> <ul id="CD005212-list-0023"> <li> <p>Consumer preference: no data.</p> </li> </ul> </p> </section> <section id="CD005212-sec-0066"> <h4 class="title">Radiotherapy followed by chemotherapy versus chemotherapy followed by radiotherapy</h4> <p>For this comparison, anthracyclines but not taxanes were used.</p> <p>One study, including 244 women, was available for this comparison (<a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>). The following results are presented such that an OR or HR of less than 1.0 favoured the group allocated to receive RT first. </p> <p> <ul id="CD005212-list-0024"> <li> <p>Local recurrence‐free survival (ipsilateral): local control was reported but only as first‐event data. We are awaiting a reply from the author and will modify future updates of this review when these data have been obtained (as of 18/03/13 this had not been provided). </p> </li> </ul> <ul id="CD005212-list-0025"> <li> <p>Cause‐specific survival at five years: no data.</p> </li> </ul> <ul id="CD005212-list-0026"> <li> <p>Overall survival did not differ between the two groups at:</p> <ol id="CD005212-list-0027"> <li> <p>five‐year follow‐up: HR 1.52; 95% CI 0.90 to 2.55 (<a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>); </p> </li> <li> <p>10‐year follow‐up: HR 1.20; 95% CI 0.76 to 1.89 (figures from the text; <a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>). </p> </li> </ol> </li> </ul> <ul id="CD005212-list-0028"> <li> <p>Metastasis‐free survival did not differ between the two groups when RT then CT versus CT then RT was compared at: </p> <ol id="CD005212-list-0029"> <li> <p>5‐follow‐up: HR 1.62; 95% CI 1.00 to 2.61 (<a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>); </p> </li> <li> <p>11.2‐year follow‐up: HR 1.08; 95% CI 0.71 to 1.64 (<a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>). </p> </li> </ol> </li> </ul> <ul id="CD005212-list-0030"> <li> <p>Relapse‐free survival did not differ between the two groups when RT then CT versus CT then RT was compared at: </p> <ol id="CD005212-list-0031"> <li> <p>five‐year follow‐up: HR 1.37; 95% CI 0.88 to 2.14 (<a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>); </p> </li> <li> <p>11.2‐year follow‐up: HR 1.03; 95% CI 0.73 to 1.46 (<a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>). </p> </li> </ol> </li> </ul> <ul id="CD005212-list-0032"> <li> <p>Mastectomy rate: no data.</p> </li> </ul> <ul id="CD005212-list-0033"> <li> <p>Harms and toxicity:</p> <ol id="CD005212-list-0034"> <li> <p>acute toxicity: neutropenic sepsis was worse with RT then CT, but other measures of acute toxicity (i.e. pneumonia, skin and haematological toxicity) did not differ (see <a href="#CD005212-tbl-0009">Table 9</a>); </p> </li> <li> <p>late toxicity: pneumonitis, cosmesis and cellulitis lymphoedema did not differ with RT then CT versus CT then RT (see <a href="#CD005212-tbl-0010">Table 10</a>). </p> </li> </ol> </li> </ul> </p> <div class="table" id="CD005212-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Acute toxicity: RT then CT versus CT then RT</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Toxicity type</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RT then CT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CT then RT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OR (95% CI)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neutropenic sepsis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bellon 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21/122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8/122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.96 (1.26 to 6.98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pneumonia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6/122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.26 (0.74 to 52.79)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Haemoglobin (CTC Grade III/IV)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4/120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.78 (0.17 to 3.58)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Platelet (CTC Grade III/IV)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15 (0.01 to 2.87)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Skin (CTC Grade III/IV)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17/115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12/112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.45 (0.66 to 3.18)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval; CT: chemotherapy; CTC: common toxicity criteria; OR: odds ratio; RT: radiotherapy. </p> </div> </div> <div class="table" id="CD005212-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Late toxicity: RT then CT versus CT then RT</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Toxicity type</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RT then CT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CT then RT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OR (95% CI)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pneumonitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bellon 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.47 (0.63 to 209.70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cosmesis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26/39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23/38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.30 (0.51 to 3.31)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cellulitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6/117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.09 (0.051 to 8.56)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lymphoedema</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8/117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4/119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.11 (0.67 to 7.21)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Brachial plexopathy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.14 (0.12 to 79.39)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval; CT: chemotherapy; OR: odds ratio; RT: radiotherapy.</p> </div> </div> <p> <ul id="CD005212-list-0035"> <li> <p>Compliance:</p> <ol id="CD005212-list-0036"> <li> <p>ability to deliver the prescribed CT dose (compliance): the RT first group received 81% of the planned CT dose, the CT first group received 88% of the planned CT dose (P = 0.01; <a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>); </p> </li> <li> <p>ability to deliver the prescribed RT dose (compliance): the median RT dose and duration of RT did not differ between the two groups (no P value was reported; <a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>). </p> </li> </ol> </li> </ul> <ul id="CD005212-list-0037"> <li> <p>Costs: no data.</p> </li> </ul> <ul id="CD005212-list-0038"> <li> <p>QoL: no data.</p> </li> </ul> <ul id="CD005212-list-0039"> <li> <p>Consumer preference: no data.</p> </li> </ul> </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD005212-sec-0067" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD005212-sec-0067"></div> <p>For women who elect to have breast‐conservation surgery for early breast cancer, achieving and maintaining local control and improving survival are of paramount importance. The Early Breast Cancer Trialists' Collaborative Group overview has shown the benefits of CT and RT as adjuvant treatments (<a href="./references#CD005212-bbs2-0045" title="Early Breast Cancer Trialists' Collaborative Group (EBCTCG), DarbyS , McGaleP , CorreaC , TaylorC , ArriagadaR , ClarkeM , et al. Effect of radiotherapy after breast‐conserving surgery on 10‐year recurrence and 15‐year breast cancer death: meta‐analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet2011;378(804):1707‐16. ">EBCTCG 2011</a>; <a href="./references#CD005212-bbs2-0044" title="Early Breast Cancer Trialists Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15‐year survival: an overview of the randomised trials. Lancet2005;365:1687‐717. ">EBCTCG 2005b</a>) and this review set out to explore whether there is an optimal sequencing of adjuvant CT and RT as part of the conservative management of women with early breast cancer. </p> <section id="CD005212-sec-0068"> <h3 class="title" id="CD005212-sec-0068">Summary of main results</h3> <p>We have been able to include data from three RCTs of two different comparisons of sequencing. The comparisons are concurrent versus sequential treatment (with CT before RT using first‐generation chemotherapeutic agents, i.e. no anthracyclines or taxanes) and RT followed by CT versus CT followed by RT (using anthracyclines but no taxanes). In both comparisons the evidence suggests that there are no major differences between the sequencing techniques in regards to mortality and local or distant recurrence. There is some evidence for differences in toxicity between sequencing techniques but most of the harms reported in the trials were not significantly different between the randomised groups and CIs were wide (see <a href="#CD005212-tbl-0006">Table 6</a>; <a href="#CD005212-tbl-0007">Table 7</a>; <a href="#CD005212-tbl-0008">Table 8</a>; <a href="#CD005212-tbl-0009">Table 9</a>; <a href="#CD005212-tbl-0010">Table 10</a>). We found that there was disparity between the patient and physician assessment of cosmesis with physicians reporting worse cosmetic outcomes than the women themselves (<a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>; see <a href="#CD005212-tbl-0008">Table 8</a>). Others have also reported this difference in the perception of cosmetic outcome (<a href="./references#CD005212-bbs2-0073" title="ThomsonHJ , PotterS , GreenwoodRJ , BahlA , BarkerJ , CawthornSJ , et al. A prospective longitudinal study of cosmetic outcome in immediate latissimus dorsi breast reconstruction and the Influence of radiotherapy. Annals of Surgical Oncology2008;15(4):1081‐91. ">Thomson 2008</a>). No data were available for costs, quality of life or consumer preference. However, caution in interpreting these results is advised as, given the low event rate for some end points such as local recurrence, the statistical power for detecting a clinically important risk difference in such outcomes is very small. </p> </section> <section id="CD005212-sec-0069"> <h3 class="title" id="CD005212-sec-0069">Overall completeness and applicability of evidence</h3> <p>The findings of this review provide reassurance that the general practice of giving CT before RT is not detrimental in terms of overall survival and toxicity in comparison with either the opposite sequence or the concurrent administration of CT and RT. However, some caveats are important in applying these results to current practice. First, the treatments in the included trials were given in the early 2000s on average and the CT regimens may not be considered optimal today. In this case, first‐generation chemotherapeutic agents were used (i.e. no anthracyclines or taxanes) in <a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a> and <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a> trials while anthracyclines were used in the <a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a> trial. Second, the surgical outcomes in the trials might be considered unacceptable today. Positive surgical margins are an independent predictor of local recurrence (<a href="./references#CD005212-bbs2-0057" title="LeongC , BoyagesJ , JayasingheUW , BilousM , UngO , ChuaB , et al. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node‐negative breast carcinoma. Cancer2004;100(9):1823‐32. ">Leong 2004</a>) but women who had positive surgical margins were eligible for the study of RT followed by CT versus CT followed by RT (<a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>). The standard of practice today would be to try to ensure negative surgical margins were achieved before RT. Finally, although the length of follow‐up in the included trials is adequate to detect differences in local recurrences, it is not yet long enough to assess the effects on breast cancer mortality even with 10‐year data for two studies (<a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>; <a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>). Local recurrence after breast‐conserving therapy reaches a peak at about two years (<a href="./references#CD005212-bbs2-0042" title="ChurnM , KellyV . Outpatient follow‐up after treatment for early breast cancer: updated results after 5 years. Clinical Oncology (Royal College of Radiologists)2001;13(3):187‐94. ">Churn 2001</a>) and continues at one per cent per year for at least the next two decades (<a href="./references#CD005212-bbs2-0056" title="KurtzJM , AmalricR , DeloucheG , PierquinB , RothJ , SpitalierJM . The second ten years: long‐term risks of breast conservation in early breast cancer. International Journal of Radiation Oncology, Biology, Physics1987;13(9):1327‐32. ">Kurtz 1987</a>; <a href="./references#CD005212-bbs2-0058" title="LippmanME . How should we manage breast cancer in the breast, or buddy, a new paradigm?. Journal National Cancer Institute1995;87(1):3‐4. ">Lippman 1995</a>). Distant recurrences and deaths from breast cancer take longer (<a href="./references#CD005212-bbs2-0045" title="Early Breast Cancer Trialists' Collaborative Group (EBCTCG), DarbyS , McGaleP , CorreaC , TaylorC , ArriagadaR , ClarkeM , et al. Effect of radiotherapy after breast‐conserving surgery on 10‐year recurrence and 15‐year breast cancer death: meta‐analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet2011;378(804):1707‐16. ">EBCTCG 2011</a>) and would not have been captured with the relatively short follow‐up of these trials. The length of follow‐up is also short for evaluation of some late toxicity namely, cardiac and second malignancy. </p> <p>It has not been possible to answer some questions with this initial version of the review. These include: </p> <p>1. Harms, costs, patient preferences and impact on the QoL</p> <p>The treatment‐related toxicity differed little between the sequencing techniques. The women treated did not report worse cosmetic outcome with concurrent CT/RT, but the physician‐reported outcomes for cosmesis were worse with concurrent CT/RT (<a href="#CD005212-tbl-0008">Table 8</a>). There was no information regarding the QoL, women's preferences or costs in the included trials. It has been shown that concurrent CT/RT can decrease a woman's QoL but this seems similar to that found with sequential therapy, and there may be an advantage for concurrent therapy arising from its shorter duration (<a href="./references#CD005212-bbs2-0061" title="Macquart‐MoulinG , ViensP , GenreD , BouscaryML , ResbeutM , GravisG , et al. Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma: side effects, quality of life, and organization. Cancer1999;85(10):2190‐9. ">Macquart‐Moulin 1999</a>). </p> <p>2. The impact of new CT regimens and biological agents</p> <p>The original standard CT regimen of CMF (cyclophosphamide, methotrexate and 5‐fluorouracil) has been superseded by anthracycline‐based regimens, particularly in high‐risk younger women (<a href="./references#CD005212-bbs2-0044" title="Early Breast Cancer Trialists Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15‐year survival: an overview of the randomised trials. Lancet2005;365:1687‐717. ">EBCTCG 2005b</a>). In theory, these regimens should be less toxic than the older regimens if delivered over the same or shorter time period. Taxanes (paclitaxel and docetaxel) are new CT agents that reduce the risk of death when used in the adjuvant setting for women with early breast cancer (<a href="./references#CD005212-bbs2-0051" title="HendersonIC , BerryDA , DemetriGD , CirrincioneCT , GoldsteinLJ , MartinoS . Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node‐positive primary breast cancer. Journal of Clinical Oncology2003;21(6):976‐83. ">Henderson 2003</a>; <a href="./references#CD005212-bbs2-0063" title="MartinM , PienkowskiT , MackeyJ , PawlickiM , GuastallaJP , WeaverC , et al. Adjuvant docetaxel for node‐positive breast cancer. New England Journal of Medicine2005;352(22):2302‐13. ">Martin 2005</a>). There is currently no information regarding the optimum sequencing of RT with taxanes. If taxanes were used sequentially with standard CT agents (<a href="./references#CD005212-bbs2-0051" title="HendersonIC , BerryDA , DemetriGD , CirrincioneCT , GoldsteinLJ , MartinoS . Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node‐positive primary breast cancer. Journal of Clinical Oncology2003;21(6):976‐83. ">Henderson 2003</a>), this would lead to an extended delay in starting RT, which has the potential to increase the local recurrence rate. Reassuringly, in one trial in which RT was delayed by the delivery of paclitaxel, there was a reduction in local recurrence for those women who had undergone breast‐conserving therapy and received paclitaxel (<a href="./references#CD005212-bbs2-0051" title="HendersonIC , BerryDA , DemetriGD , CirrincioneCT , GoldsteinLJ , MartinoS . Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node‐positive primary breast cancer. Journal of Clinical Oncology2003;21(6):976‐83. ">Henderson 2003</a>). Furthermore, new agents are continually being developed for treating women with breast cancer (e.g. trastuzumab (Herceptin®) and lapatinib), but the evidence to guide decisions about how these should be sequenced with RT is limited. The delay to start of RT in the included studies was less than seven months (see discussion of Included Studies), more modern chemotherapeutic regimens including taxanes can be delivered within this time frame, assuming no delays in CT delivery. </p> <p>3. The impact of new modes of RT</p> <p>New techniques for breast irradiation after breast‐conserving surgery are emerging, such as partial breast irradiation using a variety of methods. These techniques generally seek to reduce the amount of normal tissue radiated in order to reduce the incidence of acute and late side effects. However, there is also one completed trial (MA20) examining the role of nodal irradiation after conservative surgery. Early release of data suggest improved disease‐free survival with the addition of nodal radiation. The potential impact of this on clinical practice would be to increase the volume of tissue radiated (<a href="./references#CD005212-bbs2-0076" title="WhelanTJ , OlivottoI , AckermanI , ChapmanJW , ChuaA , NabidKA , et al. NCIC‐CTG MA.20: an intergroup trial of regional nodal irradiation in early breast cancer. Journal of Clinical Oncology. 2011; Vol. 29 Suppl:LBA1003. ">Whelan 2011</a>). Changes to the fractionation used for RT after conservative surgery should also lead to less time being needed for RT (<a href="./references#CD005212-bbs2-0075" title="WhelanT , MacKenzieR , JulianJ , LevineM , ShelleyW , GrimardL , et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node‐negative breast cancer. Journal National Cancer Institute2002;94(15):1143‐50. ">Whelan 2002</a>). If these techniques are effective, this may allow RT to be delivered quickly and easily, before prolonged courses of CT. There is currently no reliable information regarding the best sequencing of CT with these RT techniques. </p> <p>4. Concurrent administration of modern CT and RT</p> <p>The concurrent use of CT and RT minimises any delay in starting RT and the concurrent use of CMF and RT does not appear to affect objectively measured acute or late cosmetic outcomes or complications (<a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>; <a href="./references#CD005212-bbs2-0014" title="FaulC , BrufskyA , GersztenK , FlickingerJ , KunschnerA , JacobH , et al. Concurrent sequencing of full‐dose CMF chemotherapy and radiation therapy in early breast cancer has no effect on treatment delivery. European Journal of Cancer2003;39:763‐8. ">Faul 2003</a>; <a href="./references#CD005212-bbs2-0021" title="LambD , AtkinsonC , JosephD , O'BrienP , AcklandS , BonaventuraA , et al. Simultaneous adjuvant radiotherapy and chemotherapy for stage I and II breast cancer. Australasian Radiology1999;43:220‐6. ">Lamb 1999</a>). There is some non‐randomised evidence that the concurrent use of more modern anthracycline CT and RT is associated with more high‐grade skin toxicity and higher hospitalisation rates, which have been deemed by some to be unacceptable (<a href="./references#CD005212-bbs2-0015" title="FietsWE , vanHelvoirtRP , NortierJWR , van derTweelI , StruikmansH . Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients: a prospective, comparative, non‐randomised study. European Journal of Cancer2003;39:1081‐8. ">Fiets 2003</a>). We identified one ongoing study, which has completed accrual and has reported in abstract form, which will provide information about the feasibility and effectiveness of concurrent RT and anthracyclines (<a href="./references#CD005212-bbs2-0031" title="FernandoI N , BowdenSJ , FoxRP , GrieveR , BruntAM , AgrawalRK , et al. Effect of synchronous chemo‐radiation on quality of life: results from the SECRAB trial. European Journal of Cancer2011;47:S366. ISRCTN84214355 . Phase III randomised study of synchronous versus sequential adjuvant chemotherapy and radiotherapy in women with early stage breast cancer, 2012. www.ukctg.nihr.ac.uk/trialdetails/ISRCTN84214355. (accessed 20 November 2012). ">SECRAB</a>). Finally, some researchers maintain that the concurrent use of RT and paclitaxel is feasible and have reported its use without dose reductions, pneumonitis or brachial plexopathy (<a href="./references#CD005212-bbs2-0047" title="FormentiSC , VolmM , SkinnerKA , SpicerD , CohenD , PerezE , et al. Preoperative twice‐weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin‐based chemotherapy in locally advanced breast cancer: a phase I/II trial. Journal of Clinical Oncology2003;21(5):861‐70. ">Formenti 2003</a>). However, others have reported pneumonitis rates as high as 14% and have concluded that caution is required (<a href="./references#CD005212-bbs2-0072" title="TaghianAG , AssaadSI , NiemierkoA , KuterI , YoungerJ , SchoenthalerR , et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. Journal of the National Cancer Institute2001;93(23):1806‐11. ">Taghian 2001</a>). </p> </section> <section id="CD005212-sec-0070"> <h3 class="title" id="CD005212-sec-0070">Quality of the evidence</h3> <p>We studied 1166 women randomised in three studies with follow‐up to 10 years. There is high‐quality objective evidence related to the toxicity and cosmetic outcomes when concurrent RT is compared to sequential RT for early breast cancer. There is high‐quality evidence that local control and overall survival are similar for concurrent CT and RT, RT followed by CT and CT followed by RT for women with early breast cancer. </p> </section> <section id="CD005212-sec-0071"> <h3 class="title" id="CD005212-sec-0071">Potential biases in the review process</h3> <p>All three studies were at low risk of selection bias. In <a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a>, lack of blinding for objective outcomes may have introduced lead‐time bias. In <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a>, blinding reduced the risk of bias for the subjective outcomes of cosmesis and toxicity. Blinding was not mentioned in <a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a>, which makes the evaluation of objective outcomes (cosmesis and toxicity) at risk of bias. While <a href="./references#CD005212-bbs2-0001" title="ArcangeliG , PinnaroP , RamboneR , GiannarelliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early‐stage breast cancer. International Journal of Radiation Oncology Biology Physics2006;64(1):161‐7. ArcangeliG , PinnaroP , RamboneR , GiannarellliD , BenassiM . A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early stage breast cancer. Proceedings of 23rd Congress of European Society for Therapeutic Radiology and Oncology. 2004. PinnaroP , RamboneR , GiordanoC , GiannarelliD , StrigariL . Long‐term results of a randomized trial on the sequencing of radiotherapy and chemotherapy in breast cancer. American Journal of Clinical Oncology2011;34(3):238‐44. ">Arcangeli 2006</a> and <a href="./references#CD005212-bbs2-0002" title="CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer. Cancer/Radiothérapie2004;8:39‐47. CalaisG . Radiation and concomitant chemotherapy after surgery for breast cancer: Arcosein study [Irradiation et chimiotherapie concomitantes apres chirurgie pur cancer du sein: etude Arcosein]. Cancer/Radiothérapie1998;2(5):469‐74. CalaisG , BergerC , FourquetA , BossetJF , HelfreS , BreteauN , et al. of the ARCOSEIN group, France . Sequencing radiation therapy (RT) and adjuvant chemotherapy (CT) after conservative surgery for patients with stages I and II breast carcinoma. Preliminary results (acute toxicity and treatment compliance) of a randomized trial comparing RT with concomitant administration of CT versus sequential treatment. Radiotherapy and Oncology1998;48 Suppl 1:S125. CalaisG , SerinD , FourquetA , BossetJ , FavreA , OudinotP , et al. Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma. International journal of Radiation Oncology Biology Physics. 2002; Vol. 54, issue 2 (Supplement):57‐8. ToledanoA , AzriaD , GaraudP , FourquetA , SerinD , BossetJF , et al. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early‐stage breast cancer: final results of the ARCOSEIN trial. Journal of Clinical Oncology2007;25(4):405‐10. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , BreteauN , et al. Concurrent administration of adjuvant chemotherapy and radiotherapy after breast‐conserving surgery enhances late toxicities: long‐term results of the ARCOSEIN multicenter randomized study. International Journal of Radiation Oncology Biology Physics2006;65(2):324‐32. ToledanoA , GaraudP , SerinD , FourquetA , BossetJF , Miny‐BuffetJ , et al. Concurrent administration of adjuvant chemotherapy and radiation therapy after breast‐conserving surgery enhances late toxicities: long term results of the ARCOSEIN multicentre study [La chimiotherapie cocomitante de la radiotherapie augmente la toxicite tardive]. Cancer Radiotherapie2006;10(4):158‐67. ToledanoAH , BolletMA , FourquetA , AzriaD , GlogorovJ , GaraudP , et al. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast‐conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' views. International Journal of Radiation Oncology Biology Physics2007;1:66‐72. ">ARCOSEIN</a> were at low risk of bias for attrition, <a href="./references#CD005212-bbs2-0003" title="BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial. International Journal of Oncology Biology Physics2001;51 Suppl 1(3):2‐3. BellonJR , ComeSE , GelmanRS , HendersonIC , ShulmanLN , SilverB , et al. Sequencing of chemotherapy and radiation therapy in early‐stage breast cancer: updated results of a prospective randomized trial. Journal of Clinical Oncology2005;23(9):1934‐40. BellonJR , ComeSE , GelmanRS , LiX , ShulmanLN , SilverBJ , et al. Concurrent CMF and reduced‐dose radiation therapy (RT) in patients with early‐stage breast cancer: updated results of a prospective trial. International Journal of Radiation Oncology, Biology Physics2002;54 Suppl(2):57. HardenberghPH , RechtA , GollamudiS , ComeSE , HayesDF , ShulmanL , et al. Treatment‐related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. International Journal of Radiation Oncology Biology Physics1999;45(1):69‐72. RechtA , ComeSE , HendersonIC , GelmanRS , SilverB , HayesDF , et al. Sequencing of chemotherapy and radiotherapy after conservative surgery for early stage breast cancer. New England Journal of Medicine1996;334(12):1349‐55. ">Bellon 2005</a> was at high risk of bias. As we were not able to review protocols, the risk of selective reporting bias for all three studies was unclear (<a href="#CD005212-fig-0002">Figure 2</a>). </p> </section> <section id="CD005212-sec-0072"> <h3 class="title" id="CD005212-sec-0072">Agreements and disagreements with other studies or reviews</h3> <p>We found no other systematic reviews or meta‐analyses on this topic.</p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD005212-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/urn:x-wiley:14651858:media:CD005212:CD005212-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_t/tCD005212-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram (updated search results to 14 December 2011)." data-id="CD005212-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram (updated search results to 14 December 2011).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#CD005212-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005212-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/urn:x-wiley:14651858:media:CD005212:CD005212-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_t/tCD005212-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD005212-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#CD005212-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005212-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/urn:x-wiley:14651858:media:CD005212:CD005212-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_t/tCD005212-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Concurrent versus sequential (chemotherapy first), Outcome 1 Local recurrence‐free survival." data-id="CD005212-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Concurrent versus sequential (chemotherapy first), Outcome 1 Local recurrence‐free survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/references#CD005212-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005212-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/urn:x-wiley:14651858:media:CD005212:CD005212-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_t/tCD005212-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Concurrent versus sequential (chemotherapy first), Outcome 2 Relapse‐free survival." data-id="CD005212-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Concurrent versus sequential (chemotherapy first), Outcome 2 Relapse‐free survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/references#CD005212-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005212-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/urn:x-wiley:14651858:media:CD005212:CD005212-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_t/tCD005212-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Concurrent versus sequential (chemotherapy first), Outcome 3 Compliance with chemotherapy." data-id="CD005212-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Concurrent versus sequential (chemotherapy first), Outcome 3 Compliance with chemotherapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/references#CD005212-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005212-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/urn:x-wiley:14651858:media:CD005212:CD005212-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_t/tCD005212-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Concurrent versus sequential (chemotherapy first), Outcome 4 Overall survival." data-id="CD005212-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Concurrent versus sequential (chemotherapy first), Outcome 4 Overall survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/references#CD005212-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005212-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/urn:x-wiley:14651858:media:CD005212:CD005212-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_t/tCD005212-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Concurrent versus sequential (chemotherapy first), Outcome 5 Metastasis‐free survival." data-id="CD005212-fig-0007" src="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Concurrent versus sequential (chemotherapy first), Outcome 5 Metastasis‐free survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/references#CD005212-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005212-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/urn:x-wiley:14651858:media:CD005212:CD005212-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_t/tCD005212-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Radiotherapy then chemotherapy versus chemotherapy then radiotherapy, Outcome 1 Overall survival." data-id="CD005212-fig-0008" src="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Radiotherapy then chemotherapy versus chemotherapy then radiotherapy, Outcome 1 Overall survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/references#CD005212-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005212-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/urn:x-wiley:14651858:media:CD005212:CD005212-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_t/tCD005212-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Radiotherapy then chemotherapy versus chemotherapy then radiotherapy, Outcome 2 Metastasis‐free survival." data-id="CD005212-fig-0009" src="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Radiotherapy then chemotherapy versus chemotherapy then radiotherapy, Outcome 2 Metastasis‐free survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/references#CD005212-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005212-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/urn:x-wiley:14651858:media:CD005212:CD005212-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_t/tCD005212-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Radiotherapy then chemotherapy versus chemotherapy then radiotherapy, Outcome 3 Relapse‐free survival." data-id="CD005212-fig-0010" src="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Radiotherapy then chemotherapy versus chemotherapy then radiotherapy, Outcome 3 Relapse‐free survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/references#CD005212-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005212-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/urn:x-wiley:14651858:media:CD005212:CD005212-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_t/tCD005212-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Radiotherapy then chemotherapy versus chemotherapy then radiotherapy, Outcome 4 Cosmesis." data-id="CD005212-fig-0011" src="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Radiotherapy then chemotherapy versus chemotherapy then radiotherapy, Outcome 4 Cosmesis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/references#CD005212-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/media/CDSR/CD005212/image_n/nCD005212-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD005212-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Harris's classification</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cosmetic score</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Excellent</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Good</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fair</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Harris's classification</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#CD005212-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005212-tbl-0002"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">LENT/SOMA scoring scale</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Type of outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Category</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade 1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade 2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade 4</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Subjective</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Occasional and minimal, hypersensation, pruritus</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intermittent and tolerable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Persistent and intense</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Refractory and excruciating</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Objective</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oedema</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Asymptomatic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Symptomatic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Secondary dysfunction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fibrosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barely palpable, increased density</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Definite increased density and firmness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very marked increased density, retraction and fixation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Telangiectasia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 1 cm<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 to 4 cm<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 4 cm<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lymphoedema</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 to 4 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 4 to 6 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 6 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Useless arm</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Atrophy/retraction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10% to 25%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 25% to 40%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 40% to 75%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Whole breast</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ulcer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Epidermal only ≤ 1 cm<sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dermal &gt; 1 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Subcutaneous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bone exposed/necrosis</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Occasional, non‐narcotic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Regular narcotic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Regular narcotic medical intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Surgical intervention</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oedema</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Medical intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Surgical intervention/mastectomy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lymphoedema arm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elevate arm, elastic stocking</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Compression wrapping, intensive physiotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Surgical intervention/amputation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Atrophy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Surgical intervention/mastectomy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ulcer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Medical intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Surgical intervention/debridement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Surgical intervention/mastectomy</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Analytic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Photographic assessment of skin change</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes/no</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Date:</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tape measurement of breast size and arm diameter</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes/no</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Date:</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mammogram assessment of skin thickness and density</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes/no</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Date:</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes/no</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Date: computer tomography/magnetic resonance imaging assessment of size, fat atrophy, fibrosis </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes/no</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Date:</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">LENT/SOMA scoring scale</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#CD005212-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005212-tbl-0003"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Pigmentation scoring scale</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pigmentation scoring scale</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Excellent</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Good</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very poor</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Pigmentation scoring scale</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#CD005212-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005212-tbl-0004"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Harris's classification modified by Beadle cosmetic scale</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cosmetic score</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Excellent</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Good</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acceptable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very poor</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Harris's classification modified by Beadle cosmetic scale</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#CD005212-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005212-tbl-0005"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">LENT‐SOMA cosmetic outcome assessment</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Category</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Description</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very poor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very marked density, retraction, fixation and breast asymmetry 40% to 75%</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Marked distortion of nipple, breast asymmetry 25% to 40%, marked contour difference, severe hyperpigmentation, severe oedema, marked mammillary deviation </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acceptable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate distortion of nipple, absent nipple‐areola complex, breast asymmetry 10% to 25%, telangiectasia, moderate hyperpigmentation, increased density and firmness, slight oedema, prominent scar with surrounding retraction/volume loss, moderate contour difference, moderate mammillary deviation </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Good</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Minimal differences between treated and untreated breast, slight distortion of nipple, mild hyperpigmentation, breast asymmetry &lt; 10%, mild telangiectasia </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very good</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treated breast looks almost identical to untreated breast, perfect symmetry, no visible distortion </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">LENT‐SOMA cosmetic outcome assessment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#CD005212-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005212-tbl-0006"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Acute toxicity: concurrent versus sequential</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Type of toxicity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trials</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Concurrent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sequential</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OR (95% CI)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Anaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111/352</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81/358</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.54 (1.10 to 2.15)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade II/IV skin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.21 (0.51 to 2.83)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade III/IV infection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33 (0.03 to 3.20)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade III/IV neutropenia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.71 (0.36 to 1.38)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nausea or vomiting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>235/352</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>248/343</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.77 (0.56 to 1.06)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Grade III/IV oesophagitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.20 (0.37 to 141.12)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>CI: confidence interval; OR: odds ratio.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Acute toxicity: concurrent versus sequential</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#CD005212-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005212-tbl-0007"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Late Grade III/IV toxicity: concurrent versus sequential</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Toxicity type</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Concurrent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sequential</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OR (95% CI)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Atrophy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.09 (0.92 to 4.75)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Telangiectasia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.85 (1.37 to 10.87)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fibrosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.77 (0.77 to 247.54)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lymphoedema</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.02 (0.18 to 22.61)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pigmentation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12/105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.55 (1.73 to 106.19)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>CI: confidence interval; OR: odds ratio.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Late Grade III/IV toxicity: concurrent versus sequential</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#CD005212-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005212-tbl-0008"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Late toxicity (cosmesis): concurrent versus sequential</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cosmetic outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Concurrent</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sequential</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physician‐reported</p> <p>OR (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Participant‐reported</p> <p>OR (95% CI)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bad or very bad overall cosmesis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physician 43/107</p> <p>Participant 9/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physician 16/107</p> <p>Participant 8/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.82 (1.98 to 7.37)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.14 (0.42 to 3.07)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor/very poor skin colour</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physician 14/107</p> <p>Participant 3/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physician 1/107</p> <p>Participant 1/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.96 (2.06 to 123.68)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.06 (0.31 to 29.87)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Poor/very poor scar</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ARCOSEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physician 24/107</p> <p>Participant 17/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Physician 15/107</p> <p>Participant 12/107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.77 (0.87 to 3.61)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.50 (0.68 to 3.31)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>CI: confidence interval; OR: odds ratio.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Late toxicity (cosmesis): concurrent versus sequential</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#CD005212-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005212-tbl-0009"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Acute toxicity: RT then CT versus CT then RT</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Toxicity type</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RT then CT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CT then RT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OR (95% CI)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neutropenic sepsis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bellon 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21/122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8/122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.96 (1.26 to 6.98)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pneumonia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6/122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.26 (0.74 to 52.79)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Haemoglobin (CTC Grade III/IV)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4/120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.78 (0.17 to 3.58)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Platelet (CTC Grade III/IV)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15 (0.01 to 2.87)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Skin (CTC Grade III/IV)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17/115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12/112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.45 (0.66 to 3.18)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>CI: confidence interval; CT: chemotherapy; CTC: common toxicity criteria; OR: odds ratio; RT: radiotherapy. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Acute toxicity: RT then CT versus CT then RT</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#CD005212-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005212-tbl-0010"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Late toxicity: RT then CT versus CT then RT</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Toxicity type</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RT then CT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CT then RT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OR (95% CI)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pneumonitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bellon 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.47 (0.63 to 209.70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cosmesis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26/39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23/38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.30 (0.51 to 3.31)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cardiac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cellulitis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6/117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.09 (0.051 to 8.56)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lymphoedema</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8/117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4/119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.11 (0.67 to 7.21)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Brachial plexopathy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.14 (0.12 to 79.39)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>CI: confidence interval; CT: chemotherapy; OR: odds ratio; RT: radiotherapy.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Late toxicity: RT then CT versus CT then RT</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/full#CD005212-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005212-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Concurrent versus sequential (chemotherapy first)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Local recurrence‐free survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Local recurrence‐free survival at 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.14, 6.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Local recurrence‐free survival at 10 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.30, 3.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Relapse‐free survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Relapse‐free survival HR at 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.84, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Compliance with chemotherapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>901</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.35, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Overall survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Overall survival at five years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>901</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.83, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Metastasis‐free survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Metastasis‐free survival at 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.60, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Metastasis‐free survival at 10 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.20, 1.62]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Concurrent versus sequential (chemotherapy first)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/references#CD005212-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005212-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Radiotherapy then chemotherapy versus chemotherapy then radiotherapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overall survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Overall survival at 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.52 [0.90, 2.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Overall survival at 10 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.76, 1.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Metastasis‐free survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Distant metastases at 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.62 [1.00, 2.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Distant metastases at 10 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.71, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Relapse‐free survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Relapse‐free survival at 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [0.88, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Relapse‐free survival at 10 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.73, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Cosmesis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.51, 3.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Radiotherapy then chemotherapy versus chemotherapy then radiotherapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005212.pub3/references#CD005212-tbl-0012">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD005212.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD005212-note-0010">Español</a> </li> <li class="section-language"> <a class="" href="fr#CD005212-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD005212-note-0002">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ta#CD005212-note-0004">தமிழ்</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD005212-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005212\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005212\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005212\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005212\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005212\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005212\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005212\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005212\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005212\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005212\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005212\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005212\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005212\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005212\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005212\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005212\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005212\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005212\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=f00EizoA&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005212.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005212.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD005212.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD005212.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005212.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727761889"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005212.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727761893"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005212.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eb3f999e99368',t:'MTc0MDcyNzc2Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 